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Age-related macular degeneration (AMD) is a degenerative disease of the retina. The 
pathogenesis of AMD is not known, but several mechanisms have been proposed. This Master’s 
thesis introduces theories related to reduced nutrient and oxygen delivery to retina, chronic 
inflammation, oxidative stress and malfunction of mechanisms maintaining protein homeostasis.  
 
Laser heating treatment of the retina is promising treatment modality for AMD. Heating of retina 
has been observed to induce several changes in the retinal cells. One of the observed changes is 
the heat shock response. During the heat shock response, cells produce heat shock proteins (HSPs) 
that maintain protein homeostasis, inhibit the inflammatory response and prevent cell death. 
Heat shock induction after laser heating may offer a novel therapeutic approach to prevent the 
progression of AMD.   
 
The treatment temperature and duration have to be selected carefully. The temperature needs 
to be sufficiently high to induce a heat shock response but low enough to prevent cell death. With 
a longer treatment duration, a lower temperature is needed. This Master’s thesis utilizes 
electroretinography (ERG) based method to assess retinal temperature during treatment. The 
purpose of this Master’s thesis was to study how laser heating treatment affects the retinal 
function in mice. 
 
We found substantial variation in power needed to reach the same temperature increase in 
different mice. This finding supports the usage of temperature determination method during 
heating treatment. Histological analysis revealed increased HSP expression and signs of cell death 
within the heated area. The amount of HSP correlated with the used heating laser power. 
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Silmänpohjan ikärappeuma on silmän verkkokalvoa rappeuttava sairaus. Sairauden 
syntymekanismia ei tunneta, mutta siitä on esitetty useita teorioita. Tässä työssä esitellään 
silmänpohjan ikärappeuman syntyyn liittyviä teorioita, jotka käsittelevät muutoksia verkkokalvon 
ravinteiden ja hapen saannissa, kroonista tulehdusreaktiota, oksidatiivista stressiä ja solujen 
proteiinitasapainon säätelytekijöiden häiriöitä. 
 
Verkkokalvon lämmittäminen laserilla on lupaava hoitomuoto silmänpohjan ikärappeumalle. 
Verkkokalvon lämmityksen on havaittu aiheuttavan useita muutoksia verkkokalvon soluissa. Eräs 
havaituista muutoksista on lämpöshokkireaktio, jossa solut tuottavat lämpöshokkiproteiineja. 
Lämpöshokkiproteiinit ylläpitävät solun proteiinitasapainoa, säätelevät tulehdusreaktiota sekä 
ehkäisevät solukuolemia.  Lämpöshokkiproteiinien eritys lämmityshoidon jälkeen saattaa tarjota 
uuden hoitomuodon silmänpohjan ikärappeuman etenemisen pysäyttämiseksi. 
 
Hoidon aikainen verkkokalvon lämpötila ja hoidon kesto on valittava huolellisesti. Lämpötilan on 
oltava tarpeeksi korkea aiheuttaakseen lämpöshokkireaktion, mutta riittävän matala 
solukuolemien välttämiseksi. Pidemmillä lämmityksen kestoilla sopiva lämpötila on alhaisempi. 
Tässä työssä käytettiin elektroretinografiaan (ERG) perustuvaa lämpötilan arviointimenetelmää, 
joka mahdollistaa verkkokalvon lämpötilan arvioinnin hoidon aikana. Työn tavoitteena on tutkia, 
millaisia vaikutuksia laserhoidolla on verkkokalvoon. 
 
Havaitsimme hiirten välillä merkittävää vaihtelua tehossa, joka tarvittiin samansuuruisen 
lämpötilannousun aikaansaamiseksi. Tämä havainto tukee lämpötilanarviointimenetelmän käyttöä 
lämmityshoidon aikana. Histologinen analyysi paljasti lämpöshokkiproteiinien määrän lisääntyneen 
lämmitetyllä alueella sekä merkkejä solukuolemista. Lämpöshokkiproteiinien määrän korreloi 
käytetyn lämmityslaserin tehon kanssa.  
 
Avainsanat: Verkkokalvon laserhoito, pigmenttiepiteeli, lämpöshokkiproteiini, 
silmänpohjan ikärappeuma, elektroretinografia 
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Introduction 
 
Vision is considered to be the most important sense of humans. It provides us the most of 
the information about the surrounding world since the majority of human sensory cells are 
located in the retina [1]. The leading cause of irreversible vision loss in people over 50 years 
old in western countries is age-related macular degeneration (AMD) [2]. AMD has 
detrimental effects on the quality of life. AMD patients suffer more often from depression 
compared to similarly aged people without AMD [3]. In addition, AMD increases the risk of 
falls and other injuries and reduces patients’ ability to cope in everyday situations [4, 5]. 
 
AMD is a degenerative disease of the retina. The pathogenesis of AMD is not known in 
detail. However, AMD has been associated with changes in Bruch’s membrane and 
choroidal blood flow, to chronic inflammation, to oxidative stress, and to the retinal 
accumulation of cellular debris. [6] The disease is divided into wet and dry forms, dry form 
being more common [7]. Currently, there is no treatment for dry AMD [8].  
 
Laser heating of the retina is considered as a potential treatment for AMD. Laser heating 
treatments include cell death-inducing modalities as well as cell death avoiding 
subthreshold modalities. The aim of subthreshold treatments is to induce positive changes 
in retinal function by heating retinal pigment epithelium (RPE) cells. One of the observed 
heating-induced changes is the heat shock response in which RPE cells increase the 
expression of heat shock proteins (HSPs). In this Master’s thesis, we studied a specific HSP-
family, HSPA. HSPAs are molecular chaperones that assist in the correct folding of proteins, 
promote refolding and degradation of misfolded proteins and prevent the formation of 
harmful protein aggregates [9]. In addition, HSPAs are regulators of cell death and 
inflammation [10, 11]. All of these qualities may be useful in the treatment of AMD and, 
therefore, increased HSPA expression by laser heating may offer a novel therapeutic 
approach to prevent the progression of AMD. 
 
Induction of heat shock response without causing cell death requires a careful selection of 
the treatment temperature and duration. The temperature needs to be sufficiently high to 
induce a heat shock response but low enough to prevent cell death. With a longer 
treatment duration, a lower temperature is needed. The retinal temperature during the 
treatment is affected by heating laser parameters and individual properties such as fundus 
pigmentation, choroidal blood flow and transparency of ocular media [12 - 14]. Therefore, 
the same laser parameters cannot be used to induce the same temperature elevation in all 
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patients and in all locations in the patient’s retina. The lack of a method to estimate retinal 
temperature during treatment has thus slowed down the development of these 
treatments. This Master’s thesis utilizes a temperature estimation method developed by 
Pitkänen et al. [15] to assess retinal temperature during heating treatment. This method is 
based on the temperature dependent properties of electroretinography (ERG) signal. ERG 
signal is caused by changes in a flow of ions in the extracellular space of retinal cells and is 
used clinically to evaluate the retinal function and to diagnose retinal disorders [16, 17]. 
 
The purpose of this Master’s thesis was to study how laser heating treatment of the RPE 
affects the retinal function in mice. The extent of variation in treatment power needed to 
reach the same temperature elevation in different individuals was assessed and the 
accuracy of the temperature estimation method in temperatures above the temperatures 
to which the estimation method was calibrated was investigated. Moreover, the effect of 
laser treatment on retinal pigment epithelium HSPA content and cell viability was examined 
using immunostaining. In addition, the literature was reviewed to facilitate greater 
understanding of mechanisms of heat shock protein expression and function, AMD 
pathogenesis and current treatment modalities of AMD. The overall aim of this Master’s 
thesis was to provide information for the ongoing research in the Department of 
Neuroscience and Biomedical Engineering (NBE) of Aalto University aiming to develop a 
novel subthreshold heating treatment for AMD. 
 
The literature review of this Master’s thesis begins by introducing the structure and 
operation of the human eye. The second chapter explores heat shock response and focuses 
on HSPA family. Chapter three introduces AMD and is followed by Chapter four that 
outlines possible mechanisms contributing to the development of AMD. Chapter five 
presents the main treatment methods for AMD. The literature review is followed by the 
experimental part of the thesis. Chapters six and seven describe the used methods and the 
acquired results. Finally, the results are discussed in Chapter eight.   
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1. Structure and Operation of Eye 
 
To humans, vision provides more information about the surrounding world than the other 
senses together since about 70 percent of the human sensory cells are located in the eye. 
The eye is a highly specialized and adaptable organ. It allows us to see in versatile lighting 
conditions as well as to focus on objects at different distances. [1] This chapter presents 
the structure of the human eye focusing more deeply on the structure and operation of the 
retina and introduces the differences in the structure of the human and mouse eye.  
 
1.1 Human Eye 
 
Figure 1 presents the structure of the human eye. The eyeball consists of three layers. The 
outermost layer, fibrous tunic, consists of sclera and cornea. The sclera is a layer of dense 
connective tissue that supports the eye. The transparent cornea covers the anterior part of 
the eyeball. Its curved shape helps to focus incoming light onto the retina. The middle layer, 
vascular tunic, consists of the choroid, ciliary body, and iris. The highly vascularized choroid 
covers most of the inner surface of the sclera. It provides nutrition for the innermost layer 
and prevents reflection of light by absorbing it. The ciliary body and the iris are located in 
the anterior part of the eye. The iris has opening in the middle called pupil and the muscles 
of iris adjust the size of the pupil thereby controlling the amount of light entering the eye. 
The innermost layer consists of the retina which lines posterior parts of the eyeball. It 
contains photoreceptor cells capable of sensing light. [18] 
 
The area at the center of the retina is named after its yellowish pigments as macula lutea 
(in Latin macula “a small flat spot”, lute- “yellowish”). The center of the macula is referred 
to as the fovea. The fovea is the area of the highest visual acuity. [18] Optic disk is the 
location where the optic nerve exits the eye and the retinal blood vessels enter the eye. 
The optic disk lacks photoreceptor cells and therefore no visual sensation can arise from 
this region. [19] 
 
The transparent lens is located behind the pupil and iris. The ciliary body changes the shape 
of the lens to focus the incoming light to the retina. Lens divides the interior part of the 
eyeball into two cavities. The posterior cavity contains transparent gel, vitreous humor. The 
anterior cavity is divided into the anterior chamber and posterior chamber and is filled with 
aqueous humor, a transparent fluid that nourishes lens and cornea.  [18] 
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Figure 1. Structure of the human eye. [1, modified] 
 
1.2 Human Retina 
 
The retina contains several different types of cells that are organized into layers. Figure 2 
presents the structure of the retina. The outermost layer of the retina is retinal pigment 
epithelium (RPE). Photoreceptors, the light-sensing cells of the retina, are located proximal 
to the pigment epithelium. They transmit the information of light into bioelectrical signals 
in a process referred to as phototransduction. Photoreceptors consist of outer and inner 
segments. Outer segments contain photopigments that absorb incoming light. Inner 
segments, in turn, contain cell organelles such as nucleus, mitochondria and Golgi complex 
and form the outer nuclear layer of the retina. The information of light is transmitted from 
photoreceptors to bipolar cells via synapses located in the outer plexiform layer. Bipolar 
cell nuclei form the inner nuclear layer. Bipolar cells pass the information of light to 
ganglion cells via synapses located in the inner plexiform layer. The cell bodies of ganglion 
cells are located in the ganglion cell layer. Ganglion cell axons form optic nerve that 
forwards the information to the rest of the brain. [19] 
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Horizontal cells and amacrine cells modify retinal signaling via lateral connections [19]. 
Horizontal cells receive information from photoreceptor cells and are responsible for 
lateral inhibition of bipolar cells [20]. Amacrine cells have various functions in the 
information processing of the retina [21]. They receive information from bipolar cells and 
form synaptic connections back to bipolar cells, amacrine cells and ganglion cells [19]. 
 
The retina has a high metabolism and it consumes most oxygen per unit weight of the 
human tissues. It receives oxygen from two different circulatory systems: choroidal and 
retinal vessels. Retinal vessels supply oxygen and nutrients to the inner parts of the retina. 
[22] The outer retina receives nutrients and oxygen from the choroid. Photoreceptors are 
the most oxygen-consuming cells in the retina: they consume over 90 % of the oxygen 
delivered to the retina. In order to meet this high oxygen demand, the choroid has a 
especially high blood flow. The choroidal blood flow per unit tissue weight is ten-fold higher 
than in the brain. [23] 
 
 
Figure 2. The laminar structure of the retina. [18, modified] 
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1.2.1 Photoreceptor Cells 
 
Photoreceptors are divided into rods and cones. Rods are specialized to function in dim 
light whereas cones are less sensitive to light and thus function in brighter lighting 
conditions. The human retina contains three types of cones. Each of them is sensitive to a 
different spectrum of light allowing discrimination of colors. [18] Cones are divided to 
short-wavelength, medium-wavelength and long-wavelength cones that are the most 
sensitive to light with wavelength approximately 430 nm, 530 nm and 560 nm respectively 
[19]. This chapter focuses mainly on the rod cells because they were essential in the 
experimental part of this Master’s thesis.  
 
Figure 3 shows the structure of photoreceptor cells. Photoreceptor cells are divided into 
outer and inner segments. Photopigments are located in the outer segment whereas 
components necessary for the metabolism of the cell such as cell nucleus, Golgi complex 
and mitochondria are located in the inner segment. The synaptic terminal is located at the 
end of the inner segment. [18]  
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Figure 3. Photoreceptor cell structure. [19, modified] 
 
All neurons, including photoreceptors, actively maintain ion concentration differences 
between intracellular and extracellular fluid. These differences are important for cell 
viability. The differences in ion concentration between the intracellular and extracellular 
fluids creates an electrical potential difference across the plasma membrane that is 
referred to as the membrane potential. In the resting state of the cell, the intracellular fluid 
has negative potential compared to the extracellular fluid. This resting state potential 
difference is referred to as resting membrane potential, and by convention, it has a 
negative value. [19]  
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Membrane potential can change in response to alterations in the permeability of the cell 
membrane to ions [19]. The phospholipid bilayer of the plasma membrane is impermeable 
to ions but ions can move through the cell membrane via ion channels formed by proteins 
embedded in the membrane. The opening of ion channels can be regulated by binding of 
ligand molecules, membrane potential or mechanical stimulus. Cell can also move ions 
against their electrochemical gradient using exchangers and pumps. [21] Changes in 
membrane permeability can lead to hyperpolarization where membrane potential 
becomes more negative or to depolarization where membrane potential becomes less 
negative compared to the resting membrane potential [19]. 
 
Resting membrane potential of a typical neuron is -65 mV whereas resting membrane 
potential of rod in complete darkness is approximately -30 mV. This difference in resting 
membrane potential is a result of photoreceptor dark current. The dark current is caused 
by the inflow of cations such as Na+ and Ca2+ through cyclic guanosine monophosphate 
(cGMP) gated channels that are located in the outer segment. [19] This inflow is 
compensated by the outflow of K+ ions through K+ selective ion channels in the inner 
segment [18]. Na+ ions are returned to extracellular space and K+ ions to intracellular space 
by Na+/K+ pumps located in the inner segment cell membrane [21]. The dark current 
maintains rod cell depolarization [18]. In the depolarized state of the cell, L-type calcium 
channels located near the synaptic terminal are open letting Ca2+ ions into the cell. The 
open state of the L-type calcium channels facilitates intracellular calcium concentration 
that results in the release of neurotransmitter glutamate at the synaptic terminal. [21] 
 
Figure 4 shows a schematic presentation of the rod light response. When a photon arrives 
to a rod cell, it may be absorbed by a photopigment molecule, rhodopsin, in the rod outer 
segment. This absorption activates the photopigment molecule and is the first step in 
phototransduction. [19] The activation results in a conformation change in rhodopsin which 
allows it to induce separation of -subunit from G-protein transducin. Transducin -
subunit, in turn, activates phosphodiesterase (PDE) that hydrolyzes cGMP molecules and 
therefore causes a decrease in the cytoplasmic concentration of cGMP. The probability of 
cGMP gated ion channels being in open state increases when cGMP molecules are bound 
to them. Therefore, the decrease in cytoplasmic cGMP concentration leads to a higher 
probability of cGMP-gated ion channels being in a closed state. [24] Closure of cGMP gated 
channels in the outer segment reduces dark current by preventing the inflow of Na+ and 
Ca2+ ions. [19] However, the outflow of K+ ions from the inner segment continues resulting 
in hyperpolarization of the cell. This hyperpolarization leads to the closure of L-type Ca2+ 
channels and decrease in outer segment intracellular calcium concentration which results 
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in a reduction in the release of glutamate to the synaptic cleft. [21] The reduction of 
glutamate release is detected by bipolar cells [19].  
 
In addition to the inner segment, outer segment calcium concentration decreases after the 
closure of cGMP channels. Closure of cGMP channels prevents the inflow of Ca2+ ions 
through them. However, photoreceptor outer segment actively removes calcium ions and 
this removal continues during photoexcitation resulting in a decrease in the outer segment 
calcium level. [21] This reduction results in the accelerated synthesis of cGMP by activation 
of guanylate cyclase. After photoexcitation, rhodopsin, transducin and PDE are deactivated 
and the photoreceptor cell returns to its resting state. [24] 
 
 
Figure 4. Schematic presentation of the phototransduction cascade. Abbreviations used in 
the figure are: photon (hv), rhodopsin (R), activated rhodopsin (R*), transducin (G),  
subunit of transducin (G), phosphodiesterase (PDE), cGMP (cG), cGMP-gated channel 
(CNGC), guanylate cyclase (GC). [25] 
 
1.2.2 Bipolar Cells 
 
Bipolar cells can be divided into ON and OFF cells based on their response to the reduction 
of glutamate release from photoreceptors. ON bipolar cells respond to the reduction in 
glutamate by depolarizing whereas OFF bipolar cells respond by hyperpolarizing. The 
difference in response is caused by the presence of different glutamate receptors in the 
bipolar cell membrane. The receptors of OFF bipolar cells are ligand-gated ion channels, 
which have a higher probability to be open when glutamate is bound to them. When open, 
these ion channels facilitate the inward movement of Na+ ions depolarizing the cell. 
However, the light-induced reduction of glutamate release from photoreceptor cells causes 
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these ion channels to close leading to hyperpolarization of the cell. In contrast, ON bipolar 
cells have glutamate receptors that cause hyperpolarization when glutamate is bound to 
them. Therefore, these cells depolarize when glutamate release from photoreceptor cells 
decreases. [19] 
 
In addition to having direct synaptic connections to photoreceptor cell, bipolar cells are 
also connected to other photoreceptors via horizontal cells. When a photoreceptor cell 
hyperpolarizes in response to light, also the horizontal cells connected to it hyperpolarize. 
Therefore, when light is shone to the eye, ON bipolar cell may receive a depolarizing signal 
via direct connection to photoreceptor cell and additional hyperpolarizing signal via 
horizontal cells connected to other hyperpolarized photoreceptor cells. This lateral 
inhibition is one of the mechanisms that allow information processing at the outer 
plexiform layer of the retina. [19]   
 
1.2.3 Retinal Pigment Epithelium 
 
The retinal pigment epithelium (RPE) consists of a single layer of epithelial cells that contain 
high amounts of pigment granules. These granules carry melanin and are therefore referred 
to as melanosomes. [7] The RPE melanosome content varies topographically. The amount 
is lowest in the macular area and increases towards the periphery of the retina. [26] 
Topographical changes may arise from the topographical development of RPE that causes 
posterior and peripheral RPE to undergo differentiation at different times and locations. In 
addition, the variation of melanosome content among patches of cells and differences 
between cells can be remarkable.  [27] 
 
RPE cells are attached to the anterior layer of Bruch’s membrane. The apical surface of RPE 
cells faces the photoreceptor outer segments and the basolateral surface faces the Bruch’s 
membrane. RPE has close structural connections with photoreceptors by fingerlike 
processes that extend in between photoreceptor outer segments. [7]  
 
RPE has multiple important metabolic and supportive functions. It participates in the 
renewal of photoreceptor by phagocytosing and degrading the tips of photoreceptor outer 
segments. The shedding is balanced by the continuous growth of outer segments at their 
base. [28] In addition, RPE supports photoreceptor function by regenerating bleached 
visual pigments as well as transporting molecules and ions between photoreceptors and 
the choroid [28, 29]. Moreover, RPE expresses growth factors and secretes components 
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that create a specific extracellular matrix, interphotoreceptor matrix that is important for 
the maintenance of photoreceptor cells [28, 30]. 
 
1.2.4 Bruch’s Membrane 
 
Bruch’s membrane is a connective tissue that lies between RPE and choroid. It has three 
layers: two collagenous layers and elastic layer in between them. [31] Bruch’s membrane 
has several functions. It regulates the diffusion of molecules and ions between choroid and 
RPE. In addition, it provides physical support for RPE cell adhesion and surface for 
migration. Moreover it acts as a barrier that restricts the migration of choroidal cells 
preventing blood vessel growth to the retina. [7] 
 
Transport through Bruch’s membrane occurs via passive diffusion. The diffusion rate is 
affected by the composition of membrane and concentrations of particles on both sides of 
the membrane. Changes in the Bruch’s membrane related to age, genetics, environmental 
factors, and disease state affect its permeability to different substances. [7] 
 
1.3 Mouse Eye 
 
In this Master’s thesis, the effect of retinal laser heating treatment was studied with mice. 
The structure of the mouse eye is highly similar to the human eye. Figure 5 illustrates 
schematic presentations of human and mouse eye cross-sections. Differences between the 
mouse and human eye include the lack of macula, smaller eye diameter as well as larger 
pupil diameter and lens size compared to the diameter of the eye. In addition, the mouse 
has only two cone pigments corresponding to short-wavelength and medium-wavelength 
pigments found in humans. The absence of long-wavelength pigment results in the reduced 
ability of the mouse to see long-wavelength light compared to humans. [32] 
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Figure 5. Schematic presentation of the structure of human and mouse eye. [32, modified] 
 
The retinal structure of mice is similar to humans. The most prominent difference in the 
mouse retina compared to the human retina is the lack of macula. [33] Approximately 97 
% and 95 % of the photoreceptors are rods in mouse and human retina, respectively [19, 
34]. In the human retina, most of the cone cells are located in the fovea and their 
proportion reduces significantly to the periphery. The human central fovea does not 
contain rods. [19] However, the rod to cone ratio of peripheral parts of the human macula 
is similar to the central mouse retina [33]. 
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In addition, the photoreceptor cell density of mouse central retina is greater than in human 
macula. This results in the higher phagocytic load of mouse central RPE compared to the 
human macula. Moreover, the central region of both mouse and human retina has higher 
photoreceptor cell density and thinner Bruch’s membrane compared to the peripheral 
retina. However, the magnitudes of these differences between central and peripheral 
retina are larger in humans. [33] 
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2. Heat Shock Response 
 
Cells of homothermic species, such as human, have specialized to function in a specific 
temperature. Deviation from this temperature affects various cellular functions and thus 
poses a threat to their survival. Even a small increase in temperature can lead to protein 
unfolding and aggregation. Moreover, temperature increase damages cytoskeleton and 
affects nuclear processes. The extent of defects depends on the magnitude and duration 
of temperature elevation. Accumulation of these defects can lead to cell death. In order to 
cope with increased temperature, cells have developed a specific cellular response 
mechanism, heat shock response. In heat shock response, the cell increases the synthesis 
of protein repairing chaperones, heat shock proteins (HSPs). [35] HSPs are also produced 
in response to other protein-damaging stress stimuli such as ischemia, nutrient deprivation, 
irradiation and infection [36].  
 
The structure of HSPs is highly conserved across species which suggest that they play a vital 
role in cellular survival. They are present in various cellular locations such as cytosol, 
mitochondria, endoplasmic reticulum, and nucleus. [37] HSPs are divided into following 
families based on their molecular weight: HSPA (HSP70), HSPH (HSP110), HSPC (HSP90), 
DNAJ (HSP40), HSPB (small HSPs) and chaperonin families HSPD (HSP60) and HSPE (HSP10). 
[38] There are several different naming conventions for HSPs. The nomenclature proposed 
by Kampinga et al. [39] is used in this Master’s thesis. 
 
2.1 HSPA Family 
 
HSPA family is the most widely studied class of HSPs. It contains at least 13 proteins that 
are listed in Table 1. [40] HSPA family members differ from each other by amino acid 
sequence, expression level and subcellular localization [41]. Some of the HSPA family 
members are expressed constitutively whereas others are expressed in response to stress 
[40]. Stress-inducible members of HSPA family are HSPA1A, HSPA1B, HSPA6, HSPA7, and 
HSPA14 [36]. It has been proposed that the purpose of these proteins is to repair damages 
caused by abnormal conditions whereas the other HSPA family members have house-
keeping functions [41]. 
 
HSPA1A and HSPA1B are the most studied members of the HSPA family [41]. They are the 
major stress-inducible members of HSPA family. Together HSPA1A and HSPA1B are also 
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sometimes referred to as HSP70-1 or HSP70. The amino acid sequence of these two 
proteins is very similar differing only by two amino acids. [36]  
 
Table 1. Members of HSPA family [36, 39, 41] 
Protein 
name 
Other names Localization Stress-
induced 
HSPA1A HSP70-1, HSP72, HSPA1, 
HSP70, HSP1-a, HSP70-1A, 
HSP70i 
Cytosol, nucleus, lysosomes, 
cell membrane, extracellular 
exosomes 
Yes 
HSPA1B HSPA70-2, HSP70-1, HSP72, 
HSP70, HSP1-b, HSP70-1B 
Cytosol, nucleus, lysosomes, 
extracellular exosomes 
Yes 
HSPA1L Hum70t, Hsp-hom, Hsp70-
hom, HSP70-1L, HSP70-1t 
Cytosol, nucleus No 
HSPA2 HSP70-3, HSP70-2, HSP70.2 Cytosol, nucleus, lysosomes, 
cell membrane, extracellular 
exosomes 
No 
HSPA5 HSP70-5, BIP, GRP78, MIF2 Endoplasmic reticulum, 
extracellular exosomes 
No 
HSPA6 HSP70-6, HSP70B’ Cytosol, nucleus, 
extracellular exosomes 
Yes 
HSPA7 HSP70-7, HSP70B Blood microparticles, 
extracellular exosomes 
Yes 
HSPA8 HSC70, HSC71, HSP71, 
HSP70-8, HSP73 
Cytosol, nucleus, lysosomes, 
cell membrane, extracellular 
exosomes 
No 
HSPA9 HSP70-9, GRP75, mtHsp75, 
Mortalin, HSPA9B, MOT, 
MOT2, PBP74, mot-2, 
mtHsp70 
Mitochondria, nucleus No 
HSPA12A HSP70-12A, FLJ13874, 
KIAA0417 
Intracellular, extracellular 
exosomes 
No 
HSPA12B HSP70-12B, RP23-32L15.1, 
2700081N06Rik 
Intracellular, blood plasma No 
HSPA13 HSP70-13, Stch ER, extracellular exosomes No 
HSPA14 HSP70-14, HSP70L1, 
MGC131990 
Cytosol, membrane Yes 
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The HSPA family members contain two domains: the nucleotide-binding domain (NBD) at 
their N-terminal and the substrate-binding domain (SBD) at their C-terminal. NBD has 
ATPase activity whereas SBD contains peptide binding cleft and lid regions. The two 
domains are connected by a linker. [42] In addition, eukaryotic cytosolic HSPAs contain 
EEVD motif in their C-terminal region. EEVD motif is involved in binding of co-chaperones 
and other HSPs. Specialized HSPAs such as HSPA5 and HSPA9, located mainly in the 
endoplasmic reticulum (ER) and mitochondria, respectively, lack EEVD motif. However, 
these HSPAs contain localization signal in their N-terminal. In addition, the C-terminal of 
HSPA5 contains a sequence that prevents it from leaving the ER. [36] 
 
The members of the HSPA family function as molecular chaperones. They assist in the 
correct folding of newly synthesized proteins, promote refolding of misfolded proteins, 
prevent aggregation and solubilize aggregated proteins. Natively folded cytosolic proteins 
typically adopt conformation where their hydrophobic parts are left inside the protein 
whereas hydrophilic parts face the cytosol. Therefore, HSPAs are able to recognize 
misfolded proteins by their exposed hydrophobic surfaces. [9] In addition, HSPAs assist in 
the transportation of proteins between cellular compartments, participate in the assembly 
of multi-protein complexes, control the activity of vide variety of regulatory proteins and 
have immunomodulatory functions [9, 36, 41]. The function of HSPAs is supported by 
members of DNAJ and HSPC families as well as several co-chaperones such as HSPA 
interacting protein (Hip) and HSPA/HSPC organizing protein (Hop) [36]. 
 
The mechanism how HSPA assists proteins in a non-native state to fold into the native state 
is unclear [9]. However, Figure 6 presents one possible model where DNAJs, HSPCs and co-
chaperones aid HSPA in the refolding of non-natively folded proteins. In the first step of 
this model, DNAJ binds to non-native polypeptides to prevent their aggregation. DNAJ 
forms a complex with Hip and transfer the non-native proteins to HSPAs. In the ATP bound 
state, the lid region of SBD is open causing low substrate affinity and high exchange rate. 
The second step begins with the binding of the complex containing the polypeptide, DNAJ, 
and Hip to the HSPA. DNAJs interact with the ATPase domain of HSPA. This interaction 
induces conformation change that stimulates ATP hydrolysis to ADP and closure of the lid. 
Hip prevents the dissociation of ADP from HSPA. When the lid is closed, the substrate has 
high affinity and slow exchange rate and DNAJ dissociates from the complex. In the third 
step, Hop couples HSPC to the HSPA to allow the participation of HSPC to the unfolding. 
Release of ADP and Hip from the HSPA is mediated by the interaction of nucleotide 
exchange factors (NEFs) such as Bag-1. The release of ADP allows binding of a new ATP 
molecule to the HSPA and the HSPA returns to the low-affinity state releasing the unfolded 
protein. The unfolded protein can then fold into native protein or be rebound to HSPA. [36] 
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Moreover, it has been proposed that by binding to non-native proteins HSPAs are able to 
reduce the amount of free non-native proteins sufficiently low to prevent aggregation and 
therefore give proteins time to fold to their native state [9].  
 
 
Figure 6. Proposed HSPA chaperone reaction cycle [36, modified] 
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HSPA has also antiapoptotic properties [11]. Apoptosis is a cell death pathway where the 
cell activates intracellular death mechanisms and kills itself in a controlled manner [43]. 
Apoptosis can occur via two pathways: intrinsic pathway (also referred to as mitochondrial 
pathway) and extrinsic pathway (also referred to as death receptors pathway). Both 
pathways are mediated by caspases. [11] Caspases are intracellular proteolytic enzymes 
[43]. In the intrinsic pathway, intracellular stress signals induce the production or activation 
of pro-apoptotic molecules that induce the release of apoptogenic molecules such as 
cytochrome c from mitochondria. The release of  apoptogenic molecules results in the 
activation of caspases. The extrinsic pathway is activated through death receptors located 
in the plasma membrane leading to the activation of caspases. Several HSPs, including 
HSPA, have been shown to prevent apoptosis by blocking caspase activation. [11] 
 
In addition, HSPA has anti-inflammatory properties. HSPA inhibits inflammatory response 
by preventing the activation of nuclear factor-B (NFB) [10]. NFB proteins are gene 
regulatory proteins that have a central role in the initiation of inflammatory response [43]. 
NFB is normally bound to its inhibitory protein IB. However, in response to noxious 
stimuli IB is phosphorylated by IB kinase and NFB is released. Activated NFB 
translocates to the nucleus and initiates activation of several inflammation-related genes. 
HSPA prevents activation of NFB by interacting with IB kinase. [10] 
 
2.2 Regulation of Heat Shock Response 
 
The heat shock response is mainly regulated via transcriptional control that is mediated via 
heat shock factors (HSFs). The mammalian HSF protein family contains four members: HSF-
1, HSF-2, HSF-3 and HSF-4. In addition to promoting cellular survival under stress, HSFs have 
important regulatory functions related to development and lifespan. HSF-1 is the master 
regulator of heat shock response in vertebrates. Also, HSF-2 and HSF-3 seem to be related 
to the transcriptional regulation of heat shock response but their role is uncertain. [44] 
 
Figure 7 shows a schematic presentation of the HSF-1-mediated transcriptional control of 
the heat shock response. The HSF-1 protein domains from N-terminal to C-terminal are 
DNA-binding domain (DBD), leucine zipper 1-3 (LZ1-3), regulatory domain (RD), leucine 
zipper 4 (LZ4) and C-terminal transactivation domain (CTD). HSF-1 is constitutively 
expressed. In the absence of stress stimulus, HSF-1 is kept in an inactive, monomeric form. 
This form is maintained by multiple post-translational modifications and intramolecular 
binding of LZ1-3 and LZ4 domains. [45] The HSF-1 function is also repressed by chaperone 
interactions such as binding of DNAJ and HSPA to the CTD-domain. Also, HSPC together 
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with co-chaperones participates in the repression but their exact interaction site is not 
known. [45, 46] 
 
When a cell is under proteotoxic stress, the amount of non-native proteins increases. These 
non-native proteins compete for HSP with HSF. As a higher portion of HSP chaperones is 
bound to the non-native proteins, the HSF-1s are dissociated from chaperones. [47] In 
addition, the interaction between LZ1-3 and LZ4 domains is disrupted and the regulatory 
domain becomes hyperphosphorylated leading to the activation of HSF-1. Activated HSF-1 
enters the nucleus where it homotrimerizes. The inactive HSF-1 present in the nucleus can 
also activate upon stress and form trimers. [45] Homotrimerized HSF-1 molecules bind to 
specific gene sequences, heat shock elements (HSEs) that are located upstream of heat 
shock genes and increase the transcription of heat shock genes [47]. The HSF-1 function is 
inhibited by a negative feedback loop where HSPA and DNAJ bind to the C-terminal 
transactivation domain [46]. HSF-1 dissociates from the DNA, is dephosphorylated and 
returns to the cytoplasm. Finally, it binds to the HSPC multichaperone complex to resume 
its inactivated form. [45, 46] In addition to promoting chaperone transcription, HSF-1 
regulates genes related to protein degradation, ion transportation, signal transduction, 
energy generation, vesicular transport and cytoskeleton formation [46].   
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Figure 7. HSF-1-mediated transcriptional control of heat shock response. [45, modified] 
 
Moreover, HSPs are regulated post-transcriptionally and post-translationally. [36] The 
post-transcriptional regulation is mediated via micro-RNAs (miRNAs) that regulate the 
stability and translation of messenger RNAs [36, 43]. The post-translational modifications 
of HSPs are not well known. Some of their amino acids are phosphorylated but the effect 
of phosphorylation remains unknown. [36] Additionally, the function of HSPs is regulated 
by various co-chaperones [48].  
 
2.3 Heat Shock Response and Disease 
 
Changes in HSP expression are associated with several pathological states. HSPA correlates 
positively with various inflammation markers and serum HSPA levels increase with 
increasing degrees of inflammation [49]. The plasma concentration of HSPA increases with 
the progression of disease stages in heart failure patients and therefore HSPA could serve 
as a potential biomarker for the early detection of heart failure. Additionally, the high 
expression level of HSPA is related to a variety of human cancers. HSPA is important in 
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tumorigenesis and promotes cancer cell survival. HSPA overexpression in cancer cells often 
correlates to metastases and poor clinical outcome. Other diseases associated with 
changes in HSPA levels include fatty liver disease, diabetes, stroke, asthma, and renal 
disease. [36] In addition, the concentration of HSPA decreases with age leading to impaired 
protein quality control [50]. This change has been linked to age-related diseases such as 
Alzheimer's disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS) and age-
related macular degeneration [51]. 
 
Due to the relationship between heat shock protein expression and disease, modulation of 
heat shock response is seen as a potential treatment method in multiple diseases. In 
cancer, where HSPA overexpression relates to the cancer cell survival, the objective has 
been the inhibition of HSPA function. Several pharmacological agents have been studied 
and are discussed in more detail in the review by Radons [36]. On the other hand, in 
diseases related to the toxicity from misfolded and aggregated proteins, the focus has been 
in upregulation of HSPs. HSP upregulation is thought to protect cells from the disease-
associated accumulation of misfolded proteins and protein aggregates. [48]  
 
The amplification of the heat shock response has been attempted using several different 
pharmacological agents. One approach is the induction of stress to the cell. For example, 
the amount of HSPs is increased by the inhibition of the proteasomal system because it 
leads to an increased amount of misfolded proteins that compete for HSPs with HSF-1s. 
Also, inhibition of HSP90 can lead to increased HSF-1 activation. [48] However, high levels 
of HSP90 inhibitors are cytotoxic [46]. HSP90 inhibitors include geldanamycin, some 
coumarin antibiotics, (–)-epigallo-catechin-3-gallate, gedunin, AEG3482, ITZ-1 and 17-AAG 
[46, 52]. 
 
In addition, HSP synthesis is enhanced by co-inducers. Known co-inducers include aspirin 
and hydroxylamine derivatives such as bimoclomol and arimoclomol. Bimoclomol amplifies 
the HSF-1 activation by prolonging the binding of HSF-1 to the heat shock elements. [48] 
Other pharmacological agents used to modulate heat shock response include celastrol, 
HSF1A, riluzole, non-steroidal anti-inflammatory drugs and several anti-ulcer drugs such as 
geranylgeranylacetone, carbenoxolone, zinc l-carnosine, and rebamipide. However, the 
mechanism how these agents promote heat shock response is not known in detail. [46] 
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3. Age-Related Macular Degeneration 
 
Age-related macular degeneration (AMD) is a degenerative disease of the retina that leads 
to the loss of central vision [53]. AMD is the most common cause of irreversible vision loss 
in the people over 50 years old in Western countries [2]. It was estimated in 2014 that by 
2020 the global number of people with AMD is around 200 million and increases to nearly 
300 million by 2040 [54].  
 
AMD affects mainly the macular area. However, AMD-like retinal abnormalities have been 
observed also in the peripheral retina [55]. AMD affects choroid, Bruch’s membrane, retinal 
pigment epithelium and neural retina [56]. The etiology and pathogenesis of AMD are not 
known in detail. It seems that the initial pathogenesis of AMD involves RPE degeneration 
which leads to the death of photoreceptor cells due to the close relationship between RPE 
and photoreceptors. [57] The most prominent risk factor of AMD is age. Other risk factors 
include smoking, high dietary intake of saturated fatty acids, obesity, some cardiovascular 
diseases, and family history. [29, 58] This chapter describes the signs and symptoms of 
AMD. 
 
3.1 Signs of AMD 
 
AMD is diagnosed based on visual dysfunction as well as ophthalmoscopically visible 
macular findings that include geographic atrophy, choroidal neovascularization (CNV) and 
sub-RPE depositions [28]. Geographic atrophy is characterized by photoreceptor 
degeneration around the fovea and is typically horseshoe-shaped [7]. Due to the close 
relationship between RPE and photoreceptors, this degeneration is most likely caused by 
impaired RPE function and RPE cell death [57].  
 
CNV is a condition where abnormal, leaking blood vessels grow from the choroid to retina. 
[7] The choroidal blood vessel growth is regulated by growth-promoting pro-angiogenic 
factors such as vascular endothelial factor (VEGF) and growth-inhibiting anti-angiongenic 
factors such as pigment epithelium-derived factor (PEDF). Normally, there is a balance 
between these factors and it seems that CNV is caused by disturbances in this balance. 
Hypoxia, ischemia, local inflammation, and activation of the immune system increase the 
amount of pro-angiogenic factors and may, therefore, be related to the development of 
CNV. [22] Formation of new vessels in CNV usually leads to fluid accumulation and bleeding 
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below the retina causing macular edema, retinal detachment as well as scarring and thus 
result in a major decrease in central vision [29, 59]. 
 
Sub-RPE deposits can be divided by their morphology into two groups: drusen and basal 
deposits. Drusen are round-shaped, yellowish depositions of debris between the retinal 
pigment epithelium and Bruch’s membrane [2, 59]. They can be found both in the macula 
and in the peripheral retina. Drusen are categorized based on their diameter as small 
(diameter smaller than 63 m), medium (diameter from 63 to 124 m) or large (diameter 
over 124 m). They are also categorized as soft or hard depending on their appearance. [2] 
Hard drusen have discrete margins and they are usually located in the periphery of the 
retina. Soft drusen are typically larger than hard ones, have less distinct edges and are 
located in the macular area. [2, 59] Soft drusen usually appear during the late stages of the 
disease [29]. 
 
Minor amounts of small drusen are commonly found in people over 50 years and therefore 
they are considered to be part of normal aging [2]. However, their presence is a risk factor 
for AMD. Multiple larger drusen are considered as a sign of AMD. [59] Nevertheless, the 
mechanisms leading to the formation of drusen and the relation of drusen to the 
development of AMD are unknown. [29, 59] Drusen have many similarities with plaques 
and deposits observed in many age-related diseases such as Alzheimer’s disease and 
atherosclerosis [60, 61]. Common components include amyloid beta, clusterin, vitronectin, 
amyloid P, apolipoprotein E, acute phase reactants and complement components [61]. 
Similarities suggest that these diseases share common pathologic pathways [60]. 
 
Basal deposits are divided into basal linear deposits and basal laminar deposits. Basal linear 
deposits have high lipid content and they are located in the Bruch’s membrane. Basal 
laminar deposits, in turn, are located between the RPE and Bruch’s membrane. Basal 
laminar deposits contain high amounts of long spaced collagen whereas basal linear 
deposits contain primarily membranous debris. [7] 
 
3.2 AMD Classification 
 
Based on the prevalence of visual dysfunction and characteristic macular findings, AMD can 
be classified into early, intermediate or advanced (also referred to as late) AMD. Early AMD 
is characterized by the presence of a few medium-sized drusen or retinal pigmentary 
abnormalities. In intermediate AMD, the retina has at least one large drusen, several 
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medium drusen or geographic atrophy that does not extend to the center of the macula. 
Advanced AMD can be further divided into either wet (also referred to as neovascular or 
exudative) or dry (also referred to as non-neovascular, atrophic or nonexudative) form. [2] 
Approximately 10-15 % of the AMD patients have a wet form of the disease. Dry AMD is 
characterized by the presence of drusen and geographic atrophy whereas wet AMD is 
characterized by CNV. [7] The same patient can have both of the forms at the same time 
either in the same eye or in different eyes. Furthermore, dry AMD can turn into wet AMD 
and vice versa. [28] 
 
Early AMD is often asymptomatic and the vision loss is mild. However, the patient may 
experience gaps in the image, image distortion, blurred vision, decreased contrast 
sensitivity, abnormal light adaptation or decreased vision in dim lighting conditions. In dry 
AMD, the vision loss generally develops over the course of months or years starting with 
small blind spots in the vision and resulting in the loss of the central vision. In wet AMD 
major vision loss develops faster, over days or weeks, due to the sub-retinal hemorrhage 
or fluid accumulation that eventually leads to scarring of the retina. [2, 7, 62] 
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4. AMD Pathogenesis 
 
Currently, the mechanism of AMD development is not known. However, several 
pathological factors such as the reduction of oxygen and nutrient transport to the retina, 
chronic oxidative stress, chronic inflammation and decline of protein degradation have 
been linked to the development of AMD. These factors are related to each other and most 
likely function together to induce AMD pathogenesis. This chapter reviews some of the 
possible mechanisms contributing to the development of AMD. 
 
4.1 Reduced Nutrient and Oxygen Transport 
 
Retina has one of the highest metabolic activities of human tissues. In order to meet the 
high consumption of oxygen and nutrients, the retina receives blood supply via two 
sources: choroidal capillaries and retinal vessels. Capillary network of the choroid is 
referred to as choriocapillaris. Choriocapillaris is mainly responsible for blood supply to the 
avascular outer retina and retinal vessels to the inner retina. [63] In addition, the 
movement of nutrients and oxygen to the outer retina is regulated by the permeability of 
Bruch’s membrane [7].  
 
 
Age affects both choriocapillaris and Bruch’s membrane and it is possible that these age-
related changes are related to the development of AMD. The thickness of the choroid as 
well as the density and lumen diameter of choriocapillaris decrease with age leading to 
reduced choroidal blood flow [6]. Further decrease in the choroidal blood flow correlates 
with the development of AMD [6, 64]. In addition, aging results in thickening of Bruch’s 
membrane due to increased accumulation and cross-linking of collagen fibers as well as 
deposition of debris and lipids [7, 28]. These effects may relate to impaired ability to 
degrade extracellular matrix proteins such as collagen and elastin. Degradation of collagen 
and elastin is normally conducted by matrix metalloproteinases (MMPs). The function of 
MMPs is inhibited by tissue inhibitors of metalloproteinases (TIMPs), and in the aging 
retina, TIMP content increases. The increase of TIMP content can lead to sustained 
inhibition of MMPs and therefore, to reduced degradation of extracellular matrix proteins. 
[6] Subsequent thickening of the Bruch’s membrane leads to changes in membrane 
permeability that reduce transport across the membrane [6, 7]. Furthermore, 
accumulation of drusen, retinal detachment, and macular edema increase the diffusion 
distance between choriocapillaris and retina and therefore hinder the movement of oxygen 
and nutrients. [64] 
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Inadequate supply of oxygen and nutrients has several adverse effects on the retinal 
function that may contribute to the development of AMD. Reduced delivery of oxygen to 
tissue causes a state of tissue oxygen deprivation referred to as hypoxia. The retina is 
particularly prone to hypoxia because of the high oxygen consumption of photoreceptor 
cells. Photoreceptors consume 90 to 100 % of the oxygen delivered by choriocapillaris and 
therefore even small changes in the choriocapillaris function or oxygen diffusion to the 
photoreceptors may induce hypoxia in retina. [6] Hypoxia can directly lead to RPE and 
photoreceptor cell death and, additionally, it causes CNV by generating the production of 
hypoxia-inducible factors (HIFs) that activate angiogenesis by promoting VEGF expression 
[6, 64]. Hypoxia might thus start a vicious cycle where VEGF production induces growth of 
leaky vessels that cause macular edema and retinal detachment. Edema and retinal 
detachment, in turn, increase the diffusion distance of oxygen which further promotes 
hypoxia and VEGF production. [64] 
 
Besides regulating the movement of oxygen and nutrients between choriocapillaris and 
retina, Bruch’s membrane regulates the survival of adjacent RPE and choriocapillaris by 
acting as a scaffold for these cells. Therefore, age-related changes in the Bruch’s membrane 
may result in decreased cell adhesion and death of RPE cells, photoreceptors and 
choriocapillaris endothelial cells. [28]  
 
4.2 Chronic Inflammation 
 
Inflammation is the body’s response to tissue damage. The aim of inflammation is to 
dispose pathogens, toxins or foreign material at the site of tissue damage, prevent the 
spreading of injury, initiate tissue recovery and restore tissue homeostasis. Inflammation 
is mediated by the innate immune system. The innate immune system, unlike the adaptive 
immune system, is a nonspecific defense mechanism. Therefore, it is not able to adapt or 
adjust its response. [18]  
 
Even though the aim of inflammation is to protect the tissues, chronic or excessive 
inflammation can itself induce tissue damage. The chronic inflammatory response is 
hypothesized to contribute to retinal dysfunction and death in AMD. [65] Moreover, 
chronic inflammation may contribute to neuronal dysfunction and loss in various 
neurodegenerative diseases such as multiple sclerosis, Alzheimer’s disease, Parkinson’s 
disease, amyotrophic lateral sclerosis and Huntington’s disease [59, 66].  
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4.2.1 Innate Immune System and Inflammation  
 
When the innate immune system recognizes pathogens or tissue damage, it activates and 
promotes inflammation by secreting cytokines that attract immune system cells to the site 
of infection [67, 68]. This recognition is facilitated by pattern recognition receptors (PRRs). 
Ligands for these receptors, pathogen-associated molecular patterns (PAMPs), are 
expressed by invading micro-organisms but not by the host organism. In addition to 
pathogens, non-infectious factors such as trauma, excessive heat or cold, chemical insults, 
and radiation can cause tissue damage. In response to non-infectious tissue damage, dead 
cells release danger-associated molecular patterns (DAMPs) that bind to PRRs and facilitate 
activation of the innate immune system. [66, 69]  
 
Nucleotide-binding oligomerization domain-like receptors (NLRs) are intracellular PRRs. In 
response to PAMP and DAMP danger signals, some of the NLRs form large cytoplasmic 
complexes referred to as inflammasomes. NLRP3 inflammasome (nucleotide-binding 
domain, leucine-rich-containing family, pyrin domain-containing-3) has the capability to 
respond to the widest range of different danger stimuli. Its activation has been linked to 
many autoinflammatory and autoimmune disorders. [67] 
 
Innate immune system PRRs include C-reactive protein (CRP) that activates the 
complement system [7, 66]. The complement system consists of a group of proteins. It 
promotes inflammation, eliminates pathogens and enhances the immune response. In the 
normal state of the eye, the complement system is continuously activated to promote the 
elimination of potential pathogens. Intraocular complement regulatory proteins control 
the level of complement system activation. They maintain sufficient activation to eliminate 
potential pathogens and to prevent excessive complement activation than can lead to 
tissue damage. [7]  
 
4.2.2 Inflammation and AMD 
 
Retina has developed certain mechanisms to protect its delicate structure from 
inflammatory responses. RPE cells and endothelial cells of the choroidal capillaries form 
the blood-retina barrier that maintains the homeostasis of the retina [70]. Blood-retina 
barrier and the lack of lymphatic system create a physical barrier that prevents the entry 
and exit of immune system cells and larger molecules into and out of the retina. In addition, 
retinal cells such as RPE cells express immune-suppressive agents. Due to its ability to limit 
inflammatory responses, the retina is referred to as immune-privileged tissue. [71, 72] The 
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retina has its own local immune system that includes retinal innate immune cells and 
complement regulatory system. This system can be activated when retina suffers from 
noxious stimuli. [72] However, malfunction of inflammation regulation can lead to chronic 
and paranormal inflammatory response and immune-mediated damage in the retina [7]. 
 
The theory that chronic inflammation contributes to the development of AMD has been 
strengthened by the observation that alterations in immune system genes are strongly 
related to the development of AMD [73]. In addition, AMD-induced factors such as drusen 
and cell death cause inflammation [66, 74]. Moreover, AMD-induced lesions are associated 
with immune system cell recruitment and cytokines interleukin-1 (IL-1) and interleukin-
18 (IL-18) that promote inflammation [53, 65]. Nevertheless, it is unknown whether 
inflammation is the cause or result of AMD since cell death, drusen and macrophage 
recruitment may also result from inflammation [53, 65, 73].  
 
4.2.2.1 Genetic Alterations 
 
Several immune system related genetic alterations seem to be involved in the development 
of AMD. The best known genetic risk of AMD is Y402 (Tyr402-His) variant of the 
complement factor H (CFH) [73]. CFH is a regulator of the complement system. Its primary 
role is to differentiate between host organism and pathogen. Dysfunction of CFH might 
lead to excessive complement system activation and immune-mediated damage. 
Mutations in the gene coding for CFH have been associated with other diseases that involve 
local inflammation and drusen-like deposits, such as atypical hemolytic uremic syndrome, 
dense deposit disease, and atherosclerosis. [59] 
 
Besides CFH, variations in other complement system-related genes such as in complement 
factors 3 (C3) and I (CFI) as well as in regulator of complement system activation clade G, 
member 1 (SERPING1) have been associated with AMD. In addition, genetic alterations of 
immune system regulators not related to complement system have been associated with 
AMD. These include chemokine receptor CX3CR1 and chemokine C–C motif ligand 2 (CCL-
2, also referred to as monocyte chemotactic protein 1 (MCP-1)). [73] 
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4.2.2.2 Cell Death 
 
Cells can die via various pathways that can be divided into anti-inflammatory and pro-
inflammatory. In necrotic cell death, the cellular membrane is disrupted and cellular 
contents are released. These released constituents are able to stimulate the innate immune 
system and may, therefore, induce inflammation. [66] In contrast, in anti-inflammatory 
apoptosis the cellular membrane remains intact and cells are cleared by phagocytic cells. 
[65] However, if apoptotic cells are not properly cleared out by phagocytic cells, they 
undergo secondary necrosis. In secondary necrosis, the integrity of their membrane is 
disrupted which leads to the activation of the innate immune system. Microglia are the 
main phagocytic cells of the retina. If the amount of cells undergoing apoptotic cell death 
exceeds the phagocytic capability of microglia, apoptotic cells undergo secondary necrosis 
and induce local inflammation. This can be a result of either excessive amount of dying cells 
or a decrease in the amount of microglia. [66]  
 
Inflammation can itself be the cause of cell death. Pyroptosis is a cell death pathway 
induced by the activation of NLRP3 inflammasome. Pyroptosis results in cell lysis and 
release of inflammatory cytokines to the extracellular space and is therefore pro-
inflammatory. [65] 
 
In addition, the AMD-induced RPE cell death may affect the regulation of immune response 
in the retina. RPE cells modulate the immune response of the eye by secreting various 
molecules. They include molecules that trigger immune cascade and production of pro-
inflammatory mediators as well as molecules that block any possible excessive 
inflammatory response. The loss of RPE cells reduces the capability of the retina to control 
the immune system and may, therefore, lead to chronic inflammation. [59] 
 
4.2.2.3 Drusen 
 
Drusen contain many inflammation-related molecules such as the components of 
complement system, immunoglobulins, apolipoprotein E (APOE), amyloid-, vitronectin 
and fibrinogen which suggests that the formation of drusen is caused by chronic 
inflammation. [73] Moreover, the contents of drusen can induce the activation of NLRP3 
inflammasome and thus mediate inflammation [74]. For example, amyloid- is an activator 
of the alternative pathway of the complement system. [59] Therefore, it is not clear 
whether inflammation is the cause or result of drusen formation.  
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4.2.2.4 Macrophage Malfunction 
 
Macrophages are immune system cells that participate in innate immunity and maintain 
homeostasis by phagocytosing cellular debris and bacteria [18]. Retina has resident 
macrophages, microglia, that provide immune surveillance in the inner retina. In addition, 
the release of cytokines can recruit circulating monocytes from the bloodstream. [75] 
These monocytes can then differentiate into macrophages [18]. Macrophages are divided 
into M1 or M2 type cells. M1 macrophages are pro-inflammatory and produce 
inflammatory cytokines as well as toxic reactive oxygen species whereas M2 macrophages 
are anti-inflammatory and pro-angiogenic. [65]  
 
Macrophages seem to have a role in AMD. They are present near AMD-induced lesions and 
cytokines that mediate macrophage recruitment are associated with AMD. [53] The 
mechanism how macrophages are related to AMD is not known. One hypothesis is that the 
development of AMD is related to the change in the relative amounts of pro-inflammatory 
M1 and anti-inflammatory M2 types. This hypothesis is based on the idea that that M1 type 
harms retina by inducing inflammation whereas M2 type serves a more protective role by 
producing anti-inflammatory factors. [53, 76] This macrophage polarization change may be 
caused by various insults such as genetic predisposition or oxidative stress [76]. Support to 
this idea has been provided by Cao et al. [76] who observed that the ratio of transcripts of 
M1 to M2 chemokines was increased in AMD patients compared to the non-AMD patients 
indicating a shift to M1 activity in AMD patients.  
 
Additionally, M2 type cells can induce retinal damage by producing pro-angiogenic factors 
and promoting fibrosis and might thus be related to the development of CNV [53, 76]. It is 
also worth noting that the AMD-related activation of macrophages might not promote 
disease development but instead serves to protect the retina [53]. Nevertheless, the role 
of macrophages in the development of AMD is unclear. 
 
4.3 Oxidative Stress 
 
According to the current view, aging is caused by the accumulation of structural damage 
over the lifetime of the organism. A major part of this structural damage is caused by 
oxidative stress. [31] Oxidative stress occurs when there is an excessive amount of reactive 
oxygen species (ROS) due to their accelerated production or impairment of removal 
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mechanisms [66]. ROS are unstable and highly reactive oxygen-containing chemical species 
[57]. They include free radicals such as superoxide anion [31]. Free radicals are species that 
have an unpaired electron in their outermost molecular orbital. They readily give up their 
unpaired electron or take an electron from another molecule. [18] ROS also include 
powerful oxidizing agents such as hydrogen peroxide that readily remove electrons from 
other molecules [18, 31].  
 
A certain amount of ROS is required for the normal metabolism of the cell. They function 
as signaling molecules in regulatory pathways related to cell proliferation, gene expression, 
and apoptosis. However, an excessive amount of ROS can have pathophysiological 
consequences because of their highly reactive nature. Exogenous factors producing ROS 
include smoking, alcohol consumption, and exercise. [31] 
 
ROS induce damage to the molecules that they react with. In cells, this may include lipids, 
proteins, and nucleic acids. ROS cause lipid peroxidation which disturbs membrane 
integrity, fluidity and function. [31] Especially polyunsaturated fatty acids (PUFAs) are 
susceptible to lipid peroxidation because they contain many double bonds that are 
targeted by ROS [77].  The retina contains high amounts of PUFAs and is therefore prone 
to lipid peroxidation. For proteins, ROS cause oxidation which can alter the protein 
structure preventing their normal functioning. In addition, ROS generate DNA oxidation in 
nuclear and mitochondrial genomes resulting in strand breaks, base modification or DNA-
protein cross-linkages. If the DNA damage is not repaired properly, it can lead to cell death 
or replication errors. [31] 
 
4.3.1 Sources of Oxidative Stress in Retina 
 
The retina is particularly prone to oxidative stress because it contains chromophores that 
produce ROS in response to light exposure. A chromophore is a part of a molecule where 
the energy difference between two molecular orbitals corresponds to the energy of a 
photon in the visible light spectrum. Light incoming to the eye excites electron of 
chromophore from its ground state to higher energy state. The resulting excitation state is 
highly unstable and may interact with other molecules to produce ROS. [78] Chromophores 
of the retina include photoreceptor cell photopigments and lipofuscin [31]. Lipofuscin is an 
aggregate that consists mostly of oxidatively damaged protein and lipids [22]. RPE cells are 
unable to degrade lipofuscin and therefore it accumulates to RPE cells with age increasing 
the production of ROS [31, 79]. 
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Besides light exposure, ROS are generated as by-products in normal physiological processes 
including the functions of mitochondria and peroxisomes as well as enzymes such as 
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and phospholipase A2. In 
retinal cells, mitochondria are the main source of ROS. [31] Mitochondria are particularly 
vulnerable to oxidative damage due to the close proximity of mitochondrial DNA (mtDNA) 
to the ROS-producing mitochondrial respiratory chain. In addition, mtDNA is more 
susceptible to oxidative damage than nuclear DNA (nDNA) because it is not associated with 
DNA-related proteins such as histones that would protect the genetic material from 
damage. Moreover, mtDNA has no introns that would decrease the probability of oxidative 
damage occurring in crucial location. Additionally, the DNA repair mechanisms of mtDNA 
are less effective than those of nDNA. [57] Mitochondrial damage can reduce the ability of 
the mitochondria to produce energy and thereby further increase their ROS production [57, 
58].  
 
4.3.2 Prevention and Repair of Oxidative Damage in Retina 
 
Blue light is particularly harmful to the retina due to its high energy content and absorption 
to lipofuscin [80, 81]. The retina contains various pigments that protect it from blue light 
by absorbing it. These pigments include melanin and carotenoid pigments lutein, 
zeaxanthin and mesozeaxanthin. Together lutein, zeaxanthin, and mesozeaxanthin are 
referred to as macular pigment. [31] 
 
Moreover, lutein, zeaxanthin and mesozeaxanthin act as antioxidants [82]. Antioxidants 
are substances that reduce oxidative stress by inactivating free radicals [18]. Enzymatic 
antioxidants such as superoxide dismutase, glutathione and catalase serve a key role in the 
prevention of oxidative damage [31]. Other antioxidants protecting the retina from 
oxidative damage include melanin and vitamins such as vitamin C and E [31, 81].  
 
Oxidatively damaged proteins, lipids, and nucleic acids can cause further damage to the cell 
and need to be either repaired or degraded. Lipid peroxidation products are removed by 
phospholipase enzyme and peroxisomes. The oxidative damage of DNA is repaired by 
specific DNA repair mechanisms. [31] Repair of oxidatively damaged proteins is conducted 
by HSPs, which also prevent aggregation of damaged proteins. The degradation of 
misfolded proteins is carried out by the ubiquitin-proteasome system or lysosomal system 
and is discussed in more detail in Chapter 4.4. [29] However, these mechanisms are 
incapable of completely protecting the cells from oxidative damage that accumulates 
during aging and causes cell dysfunction and death. In many tissues, dead and 
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dysfunctioning cells are replaced from stem or progenitor cell populations. However, the 
vertebrate retina is not able to regenerate and therefore the accumulation of oxidative 
damage poses a threat to the aging retina. [31]  
 
4.3.3 Oxidative Stress and AMD  
 
The risk factors of AMD support the role of oxidative stress in the development of the 
disease. Most of the known risk factors of AMD such as cigarette smoking, exposure to 
sunlight and low dietary intake of antioxidants are related to the oxidative stress. The toxic 
compounds of cigarette smoke and exposure to intense light may both induce production 
of ROS. [57] Antioxidants, in turn, have an important role in the prevention of oxidative 
damage. Cigarette smoke can, however, decrease antioxidant capacity. [31, 57]  
 
Figure 8 presents a mitochondria-based model proposed by Liang and Godley [57] that 
associates oxidative stress and the development of AMD. In this cyclic model, initial ROS 
produced by exogenous and endogenous factors leads to the production of an increasing 
amount of ROS. ROS induce damages to mtDNA and due to inefficient mtDNA repair, these 
damages accumulate to the mtDNA causing eventually mitochondrial dysfunction. 
Malfunctioning mitochondria, in turn, produce more ROS, which increases the amount of 
oxidative damage. Further mitochondrial damage induces a reduction of energy production 
which results in RPE dysfunction as well as apoptosis and ultimately leads to the 
development of AMD. [57]  
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Figure 8. Mitochondria-based model for the development of AMD. [57, modified] 
 
4.4 Dysfunction of Degradation of Misfolded Proteins  
 
Proteins are polypeptides that have been folded in a specific way. During folding, non-
covalent interactions form between amino acids and these interactions determine the final 
shape of the molecule. Folding proceeds spontaneously in the direction that is energetically 
most favorable and is assisted by molecular chaperones. The three-dimensional structure 
of a protein is important for its correct function. Therefore, damaged or misfolded proteins 
are normally unable to function properly and may form aggregates that are harmful to the 
cell. [43] 
 
In cytoplasmic proteins, the hydrophobic residues of the polypeptide are located in the 
inner parts of the protein whereas the hydrophilic residues are left facing cytoplasm. 
Damaged and misfolded proteins are recognized by molecular chaperones such HSPs by 
their exposed hydrophobic region. [43] HSPs can repair misfolded or damaged proteins and 
prevent their aggregation [9]. If HSPs are unsuccessful in the repairment of the proteins, 
proteins are assigned to degradation [43]. Two major pathways of protein degradation are 
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the ubiquitin-proteasome system (UPS) and the lysosomal system. UPS is responsible for 
the degradation of most short-lived proteins as well as damaged and abnormal proteins 
whereas the lysosomal system is responsible for the degradation of most long-lived 
proteins, protein aggregates, and cellular organelles as well as extracellular material. [43] 
[83] Besides degrading damaged proteins, UPS and lysosomal system regulate many 
cellular processes by controlling the lifetime of proteins and by recycling amino acids. [83]  
 
4.4.1 Ubiquitin-Proteasome System 
 
In the ubiquitin-proteasome system, the proteins assigned for degradation are marked with 
ubiquitin. Marked proteins are then transferred to proteasome which degrades them. 
Proteasomes are barrel-shaped proteins that contain multiple subunits. Subunits are 
assembled into four stacked protein rings around the central cavity. Proteasomes contain 
many protease enzymes that are able to degrade proteins. The active sites of protease 
enzymes are directed towards the inner space of the proteasome. Ends of the barrel are 
associated with cap protein complexes through which the proteins designated for 
degradation are guided to the proteasome core. As they move through these cap proteins, 
ATP-driven reaction unfolds the target proteins. Unfolded proteins are then degraded by 
the protease enzymes. [43]  
 
4.4.2 Lysosomal System 
 
The lysosomal system degrades both intracellular and extracellular material. Degradation 
occurs in specialized, membrane-bound organelles, lysosomes. Lysosomes contain various 
hydrolytic enzymes that break down cellular molecules. These hydrolytic enzymes are 
active in the acidic environment of the interior of the lysosome but lose their activity if they 
are released to the approximately neutral cytoplasm. This mechanism protects the cells 
against leaking lysosomal contents. [43] 
 
Lysosomes digest material via various pathways. Autophagy is a lysosomal degradation 
system that maintains cellular homeostasis by degrading various intracellular components 
such as proteins and organelles [79]. There are three different autophagic routes: 
macroautophagy, microautophagy, and chaperone-mediated autophagy. Macroautophagy 
is considered the major autophagic route. Macroautophagy starts by the enclosure of the 
debris by a double membrane which creates autophagosome. This autophagosome then 
fuses with lysosome forming autolysosome where the degradation is finalized. [84] 
Microautophagy, on the other hand, is uncommon in mammals [59]. In microautophagy, 
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cytosolic proteins and organelles are degraded by lysosomes without the formation of 
autophagic vacuole [79]. In chaperone-mediated autophagy, chaperone HSPA8 recognizes 
proteins with a specific amino acid motif and transports them to the lysosome. [59, 84] 
Because macroautophagy is the main autophagic route in mammals, it is hereafter referred 
to as autophagy.  
 
Endocytosis is a process where the cell takes up extracellular components. There are two 
kinds of endocytosis: pinocytosis where cells ingest small extracellular solutes and fluid, 
and phagocytosis where cells ingest large extracellular particles. Phagocytosis is most 
efficient in phagocytes which are cells that have specialized to the digestion of large 
particles, micro-organisms, and dead cells. In phagocytosis, cell ingests the particles to large 
endocytic vesicles referred to as phagosomes. These phagosomes then fuse with lysosomes 
where the degradation of the particles occurs. [43] RPE cells allow the regeneration of 
photoreceptor outer segments by phagocytosing outer segment tips [29].  
 
4.4.3 AMD and Dysfunction of Degradation of Misfolded Proteins 
 
Aging decreases the function of both UPS and lysosomal system. The mechanisms how 
these declines occur is unknown. [83] Age-related changes include accumulation of 
ubiquitinated proteins in cells, increase in lysosomal volume, decrease in lysosomal stability 
and decrease in the activity of some lysosomal hydrolases [79, 83]. Aging also induces 
accumulation of indigestible materials such as lipofuscin into the lysosomes decreasing 
their ability to fuse with autophagosomes. The mechanism how lipofuscin induces this 
lysosomal inhibition is not known. However, A2-E fluorophore of lipofuscin has been shown 
to increase the lysosomal pH which leads to inhibition of lysosomal hydrolases and 
therefore prevention of lysosomal degradation. [79]   
 
The decreased function of UPS and lysosomal system leads to the accumulation of toxic 
debris inside cells [83]. It is therefore hypothesized that decreased UPS activity and 
lysosomal function have a role in aging as well as in the development of many age-related 
diseases such as AMD [74]. Changes in UPS and lysosomal system have been associated 
with the development of multiple neurodegenerative diseases such as Parkinson’s disease 
and Alzheimer’s disease [83].  
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4.5 Multifactorial Nature of AMD  
 
AMD is most likely a multifactorial disease. The possible mechanisms leading to AMD 
development discussed previously in this chapter are highly interrelated. Figure 9 presents 
one theory of how different mechanisms may act together to induce AMD pathogenesis. 
In this figure, RPE phagocytosis of photoreceptor outer segments causes accumulation of 
lipofuscin to the RPE cells. Lipofuscin both induces the generation of ROS when exposed to 
light and inhibits the lysosomal system. Oxidative stress then promotes mitochondrial 
damage, which leads to the generation of more ROS. This ROS together with ROS from 
other cellular sources cause protein misfolding. Misfolded proteins that are not degraded 
by UPS or lysosomal system form aggregates that activate NLRP3 inflammasomes and thus 
induce inflammation. Accumulated protein aggregates are removed from the cell by 
exocytosis and form drusen. [58]  
 
 
Figure 9.  Possible mechanism of AMD development [58, modified] 
 
In addition to this, also other mechanisms may take place. For example, inflammation can 
promote ROS production and oxidative stress can inactivate proteasomal function [85, 86]. 
Moreover, hypoxia increases ROS production and can lead to cell death that promotes 
inflammation. On the other hand, inflammation can generate hypoxia because of the 
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increased metabolic activity of the tissue. [87] Due to these multiple interactions between 
presented mechanisms it is difficult to determine what the initial cause of AMD is. 
 
The reason why macula is more susceptible to degeneration is not known. One proposed 
reason is the high density of photoreceptor cells in macula, which exposes RPE cells to 
higher metabolic load. [88] Furthermore, Bruch’s membrane structure is different at 
macula [89]. Chong et al. [89] showed that the elastic layer of Bruch’s membrane is three 
to six times thinner and two to five times more porous in the macular region compared to 
the peripheral region. They hypothesize that this difference may contribute to the higher 
susceptibility of the macular retina to AMD. [89]  
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5. Current Treatment of AMD 
 
Currently, there are no effective treatments for dry AMD. For wet AMD, there are 
treatments that are able to slow or halt the progress of the disease but no treatment exist 
that can cure or reverse the course of the disease. [8] Therefore, prevention of AMD is 
crucial. Lifestyle recommendations aiming to prevent the development of AMD are based 
on the known risk factors of the disease. It is recommended to quit smoking, reduce the 
dietary intake of saturated fats, transfats, and omega-6 fatty acids, maintain a healthy 
weight as well as blood pressure and diet that provides sufficient amount of antioxidants. 
[2, 8] 
 
Due to the uncertainty of the pathological mechanism of AMD, the development of the 
treatment is challenging. This chapter discusses the main treatment methods of AMD.  
 
5.1 Oxidative Stress-Related Methods 
 
Antioxidants protect cells against oxidative stress and, therefore, it is hypothesized that 
they have an important role in the prevention of AMD [2]. Some antioxidants, such as 
carotenoids, cannot be produced by humans and are therefore acquired only from food 
[90]. In addition to antioxidants, adequate intake of minerals is important for the proper 
regulation of antioxidant system [81]. Therefore, antioxidant and mineral supplements are 
a common approach in the prevention of AMD.   
 
The effects of lutein, zeaxanthin, zinc, copper as well as vitamins C, E and A on AMD have 
been extensively studied [91, 92]. Even though the results of these studies have been 
inconsistent, the majority of the studies support the protective nature of lutein and 
zeaxanthin [81, 91, 92]. Age-Related Eye Disease Study (AREDS), a clinical trial that enrolled 
3640 participants, concluded that daily doses of vitamin C (500 mg), vitamin E (400 IU), -
carotene (15 mg), zinc (80 mg as zinc oxide), and copper (2 mg as cupric oxide) reduce the 
probability of developing advanced AMD in individuals with high-risk characteristics [93]. 
AREDS was continued with AREDS2 which concluded that the -carotene should be 
substituted with lutein and zeaxanthin [94]. Nevertheless, unnecessary antioxidant 
supplementation should be avoided because antioxidants can also act as pro-oxidants at 
high concentrations or have other adverse effects [31, 91]. For example, vitamin E is related 
to increased prostate cancer risk and heart failures in patients with vascular disease or 
diabetes mellitus [91].  
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Oxidative stress damages mitochondria and thus reduces their energy production. 
Metformin increases cell energy production and therefore it has been proposed to aid 
retina to withstand oxidative stress. Metformin is thought to regulate metabolism by 
activating adenosine monophosphate-activated protein kinase (AMPK) signaling. When 
activated, AMPK increases cell energy production by increasing glycolysis and promoting 
mitochondrial biogenesis. Metformin is an FDA approved drug that is prescribed for control 
of serum glucose levels in type 2 diabetes. [95] Xu et al. [95] observed that metformin can 
delay or prevent the degeneration of photoreceptors and RPE in three different retinal 
degeneration mouse models by increasing mitochondrial biogenesis and reducing oxidative 
stress.  
 
Additional approach has been the reduction of ROS production in retina. Since damaged 
mitochondria are major ROS producers in the retina, there have been attempts to enhance 
their degradation by autophagy. Tested stimulators of autophagy include rapamycin and 
lithium. [31] Wilkinson et al. [96] showed that rapamycin slows the aging of mice and 
Harrison et al. [97] reported that rapamycin extends the lifespan of mice. However, more 
results are needed of the effect of rapamycin in human retinal aging. 
 
5.2 Macular Translocation Surgery and RPE Replacement Approaches 
 
According to current understanding, RPE malfunction is central in the events leading to the 
development of AMD. Because RPE cells are not capable of self-renewal, the replacement 
of diseased RPE cells has gained attention. [98] One of the proposed methods is macular 
translocation surgery where photoreceptors of macular area are moved to the area of the 
retina where RPE is healthy. During macular translocation surgery, the retina is detached 
from RPE and the macula is rotated axially. This method has been observed to increase 
visual acuity. However, the method is not commonly used because it involves difficult 
surgical procedures and may cause severe complications such as strabismus. [99]  
 
Additionally, visual improvement has been obtained by transplanting autologous 
peripheral RPE underneath the fovea. However, these methods remain experimental due 
to the limited sources of autologous RPE tissue as well as challenges related to the tissue 
collection. In addition, autologous RPE shares the same genetic defects than diseased RPE 
and therefore, other RPE tissue sources such as fetal and non-autologous adult RPE might 
prove more suitable. However, these sources are limited and their use poses major ethical 
and technical issues. Another potential source is RPE cells derived from pluripotent stem 
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cells. [98] Possible pluripotent cells include human embryonic stem cells (hESC) and human-
induced pluripotent stem cells (iPSC) [100]. iPSCs are differentiated somatic cells that are 
altered to become pluripotent. Therefore, in contrast to hESCs, iPSCs derived RPE cells 
would be patient-specific and thus prevent any immune rejection related issues. [98] 
 
Even though mammalian RPE cells are non-proliferative, RPE cells have been activated in 
vitro to a self-renewing retinal pigment epithelial stem cells (RPESCs). These cells are 
another potential cell source for RPE replacement therapy. [100, 101] Additional possible 
sources include stem cells isolated from the umbilical cord and neural progenitor cells 
[100].  
 
In addition to finding a proper source of stem cells, the delivery method has to be 
established [98]. Investigations concentrate on two different therapeutic strategies for 
delivering the RPE cells: injection of cell suspension and surgical implantation of RPE 
monolayer with or without a supporting membrane. From these two options, the injection 
is less invasive but injected cells are more likely to form clusters and show limited 
phagocytosis of photoreceptor outer segments. Studies in animal models suggest that the 
implanted monolayers survive longer without evidence of tumor formation. [100] Further 
studies are needed to answer the questions about long-term survival, function and immune 
rejection of implanted cells as well as questions about the long-term safety of the 
procedure [98]. 
 
5.3 Intravitreal Anti-Angiogenic Therapy 
 
Intravitreal anti-angiogenic therapy is the main therapy for wet AMD. In this method, 
antiangiogenic agents are injected to the vitreous. Injection allows the localization of the 
effect to the eye. However, injections can induce adverse effects such as retinal 
detachment, intraocular hemorrhage, increased intraocular pressure and anaphylaxis. [2] 
Most commonly used intravitreal anti-angiogenic agents are ranibizumab, bevacizumab, 
and aflibercept. Ranibizumab and aflibercept are approved by the FDA for the treatment 
of wet AMD. Bevacizumab is FDA approved for the treatment of several cancer types but it 
is used as an off-label drug for the treatment of wet AMD. [8]  
 
Ranibizumab, bevacizumab, and aflibercept are able to prevent legal blindness in patients 
with wet AMD.  However, to be effective, they need to be administered frequently. The 
frequency of injections varies. Treatment can be given in a fixed monthly interval or interval 
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can be decided depending on the disease state that is evaluated during monitor visits. 
Frequent injections and monitor visits are costly and inconvenient for the patient. 
Therefore, there is a need for treatments that have longer-lasting effects. [8] Additional 
concern is the possible leakage of the antiangiogenic agents to the bloodstream through 
AMD-induced damages in the blood-retina-barrier. Systemically administered 
antiangiogenic agents have been associated with serious adverse effects such as 
thromboembolic events and death. [2] 
 
5.4 Anti-inflammatory Agents 
 
One experimental approach to the treatment of AMD is the reduction of chronic 
inflammation by using anti-inflammatory agents. Studied anti-inflammatory agents include 
corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), immunosuppressive 
agents (such as methotrexate and rapamycin) and biologics (such as infliximab, daclizumab 
and complement inhibitors).  [102] 
 
In addition to their anti-inflammatory properties, corticosteroids have anti-angiogenic, 
anti-fibrotic and anti-permeability properties that may prove useful in the treatment of 
AMD. They can reduce the permeability of choroidal endothelial cells, inhibit the activation 
of MMPs, and reduce the expression of VEGF. For example, corticosteroid dexamethasone 
has been examined in the treatment of wet AMD as a combined treatment with verteprofin 
photodynamic therapy and anti-VEGF agents with promising results. [102] Adverse effects 
of corticosteroids include cataract formation and increase in intraocular pressure that can 
lead to the development of glaucoma. [102, 103] 
 
NSAIDs have anti-inflammatory properties and they reduce pain as well as fever. In contrast 
to corticosteroids, NSAIDS do not induce an increase in intraocular pressure and may thus 
provide a safer treatment alternative. However, topical administration of NSAIDs has been 
observed to induce allergy and hypersensitivity related problems as well as corneal toxicity. 
[102] Aspirin is the most studied NSAID in the treatment of AMD. Yet, the results remain 
inconsistent. [104] 
 
Because of its key role in innate immunity, various regulators of the complement system 
have been targeted in AMD treatment. [102] Studied complement system inhibitors 
include lampalizumab, ARC1905, TNX-234, eculizumab and POT-4 [8, 102]. Lampalizumab 
was considered as the most promising therapeutic agent for dry AMD [8]. However, in two 
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phase 3 clinical trials reported by Holz et al. [105] lampilizumab failed to reduce AMD-
related geographic atrophy.  
 
5.5 Photodynamic Therapy 
 
Due to the clear optical pathway to the fundus, laser light can be used to activate drug 
molecules in the retina and RPE. In photodynamic therapy (PDT), light-sensitive dye 
verteprofin is administered intravenously where it concentrates in CNV-related blood 
vessels. When activated by 689-nm laser beam, verteprofin induces the formation of highly 
reactive singlet oxygen that damages the endothelial cells and causes occlusion of the new 
vessels. [22] The selectivity of verteprofin to the CNV allows directing the treatment to the 
lesion and prevents the damaging of surrounding tissues [8].  
 
The beneficial effects of PDT have been demonstrated by the Treatment of Age-Related 
Macular Degeneration With Photodynamic Therapy (TAP) Study Group [106] and the 
Verteprofin in Photodynamic Therapy Study Group [107]. PDT does not improve vision but 
limits the wet AMD-related vision loss [106, 107]. However, the results of PDT are 
unpredictable and prone to AMD recurrence. Therefore, if PDT is used, it is often used in 
combination with another treatment method such as intravitreal antiangiogenic therapy. 
[8] 
 
5.6 Laser Heating Treatment 
 
The aim of retinal laser heating treatment is to induce positive changes in the retinal tissue 
by heating it with laser light. When laser light is shone to the eye, it is absorbed by ocular 
pigment molecules. [108] As the light is absorbed by tissue, its energy is transformed to 
heat. Heat is conducted from the heated area to the surrounding, cooler tissues. [109] The 
laser-induced retinal temperature increase is proportional to laser power and spot size, 
exposure duration, laser wavelength, fundus pigmentation, choroidal blood flow and 
transparency of ocular media [12, 13, 14].  
 
The major ocular pigments are melanin, hemoglobin, and xanthophyll. Melanin is found in 
the RPE and choroid. It absorbs the majority of incoming light in the visible and near-
infrared spectrum. Xanthophyll is found mostly in the macular area and absorbs blue light. 
[108] Hemoglobin is a protein found in red blood cells [18].  It has high absorbance for blue, 
green and yellow light but has poor red and infrared light absorption [108, 110].  
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Figure 10 shows temperature profiles in the fundus in response to different wavelengths 
of light. The data in Figure 10 is calculated by Vogel et al. [111]. In these calculations, the 
scattering of light before retina and reflection from sclera are not taken into consideration. 
[111] The absorbance of melanin, hemoglobin, and xanthophyll decreases with longer 
wavelengths [110, 111]. As shown in Figure 10, decreased absorbance tends to shift the 
temperature elevation towards deeper tissues. In addition, when using a longer 
wavelength of light, the higher laser intensity is needed to produce the same temperature 
increase. [111] Moreover, at longer infrared wavelengths, the absorbance of water 
increases preventing the penetration of light [112]. 
 
 
Figure 10. Calculated temperature profiles during laser treatment. The diameter of the 
laser beam is 500 m and heating duration is 100 ms. T is the maximal temperature 
increase in each location z. Data is normalized to have the same temperature elevation at 
RPE for all wavelengths. A is the total percentage of light absorbed by RPE and choroid. 
[111] 
 
45 
 
There are several different treatment modalities for retinal laser therapy. These modalities 
include methods designed to cause retinal cell death, methods that aim to limit cell death 
to RPE cells and methods that aim to avoid cell death completely.  
 
5.6.1 Photocoagulation 
 
Laser photocoagulation is the oldest laser treatment modality. The aim of this treatment is 
to induce visible burns to the retinal tissues. In photocoagulation, the retina is heated with 
a high-power laser. [113] This induces temperature elevation that causes proteins to lose 
their three-dimensional structure and form aggregates in a process referred to as 
coagulation [114]. The coagulation can be observed during treatment as a decrease in 
transparency of neural retina. [113] 
 
Photocoagulation has been used to treat choroidal neovascularization in wet AMD [115]. 
However, the mechanism how photocoagulation could improve the retinal state is not 
known [108]. One hypothesis is that photocoagulation-induced heat damage in the 
capillaries causes the formation of clots that block the capillaries and prevent leakage of 
blood. Other idea is that photocoagulation reduces hypoxia in the retina. In the normal 
retina, oxygen diffuses from choriocapillaris to the retina and is mostly consumed by 
photoreceptors. Photocoagulation causes the death of photoreceptors allowing oxygen to 
diffuse deeper to the retina and thus increases retina’s oxygen concentration. [108] Aiello 
et al. [116] observed that hypoxia increases VEGF expression in retinal cells. Therefore, the 
reduction of hypoxia could reduce VEGF expression and thus prevent neovascularization. 
[116] This idea is supported by an observation made by Lip et al. [117] that 
photocoagulation decreases VEGF production in patients suffering from retinal 
neovascularization related to either diabetes or ischemic vein occlusion. In addition, 
reduced hypoxia could reduce vasodilatation and endothelial stretching that promote 
neovascularization [118]. Elevated VEGF expression in response to stretching of retinal 
endothelial cells was observed by Suzuma et al. [119]. 
 
Nevertheless, photocoagulation is associated with several adverse effects including visual 
field defects, alterations in color vision and reduced contrast sensitivity [115]. Since 
photocoagulation induces permanent damage to the neural retina, it could only be used 
for a limited number of patients where the positive effects outweigh the adverse effects of 
the treatment. Moreover, photocoagulation treatment leads to a high prevalence of 
recurrences and, therefore, in the treatment of CNV, photocoagulation has nowadays been 
mostly replaced with intravitreal anti-angiogenic therapy [115, 120].  
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5.6.2 Neural Retina Sparing Methods 
 
In order to overcome problems related to photocoagulation, new laser treatment methods 
that avoid damaging neural retina have been developed. These methods can be roughly 
divided into two groups: methods aiming to cause RPE cell death and to cell death avoiding 
subthreshold methods. RPE cell death-inducing methods include nanosecond laser therapy 
and selective retinal therapy (SRT) [56]. Promising results of nanosecond laser therapy was 
obtained by Guymer et al. [121] who observed slowing of AMD progression in a specific 
subgroup of AMD patients. In both nanosecond laser therapy and SRT, temperature 
elevation is concentrated in a small area by using a pulsed laser instead of continuous laser 
[56, 122]. Nanosecond laser therapy utilizes laser pulses in nanosecond range whereas SRT 
utilizes microsecond long laser pulses [113, 123]. Figure 11 shows how the laser pulse 
duration affects the resulting temperature profile during laser treatment. Laser pulses 
lasting 1 s cause localized temperature elevation around light-absorbing melanosomes 
that are presented in Figure 11 as high-temperature peaks within RPE. [124] Localized 
temperature elevation causes vaporization of the cytoplasm that surrounds melanosomes 
resulting in the formation of microbubbles. Microbubbles disrupt the structure of RPE cells 
leading to cell death. [113, 125]  
 
Subthreshold methods include transpupillary thermotherapy (TTT), thermal stimulation of 
the retina (TS-R) and subthreshold diode micropulse photocoagulation (SDM). These 
methods avoid causing retinal cell death. In TTT and TS-R, the retina is heated using a 
continuous laser. [56, 125] Used laser pulse durations are 60 s in TTT and 10 ms in TS-R  [56, 
123]. As shown by Figure 11, longer laser pulse duration allows heat conduction to a larger 
area [124]. Laser power in TTT and TS-R is low and the aim is to produce a smaller 
temperature increase than in photocoagulation. [56, 126] Aim in TTT is to produce less than 
10C temperature rise instead of the temperature increase ranging from 33-63C used in 
photocoagulation. [127, 128] In SDM, the temperature increase is directed to RPE by using 
micropulsed laser [129]. However, to avoid cell death, lower power and longer pulse 
duration (0.1 – 0.3 ms) are used than in SRT, which results in milder temperature elevation 
and spread of heat to a larger area [123]. 
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Figure 11. The calculated temperature profile in the pigment epithelium and neural retina 
after laser treatment with laser wavelength 514 nm, laser diameter 110 m and energy 2 
J with varying heating pulse durations. [124, modified] 
 
5.6.2.1 Treatment Mechanisms 
 
Heat shock response after retinal laser treatment is a well-known phenomenon. Increased 
HSPA expression after subthreshold laser treatment has been observed in rabbit choroid 
by Desmettre et al. [130, 131], in mouse retina by Sramek et al. [132], in rat optic nerve 
head by Kim et al. [133], in rat retina by She et al. [134], in rabbit RPE by Lavinsky et al. 
[123] as well as in cell culture of porcine RPE by Kern et al. [135], rabbit RPE by Wang et al. 
[136] and in immortal human RPE cell line (ARPE-19) by Inagaki et al. [137] .  
 
As discussed in Chapter 2.1, HSPAs act as chaperones preventing protein aggregation and 
repairing misfolded proteins. It is hypothesized that these properties can prove useful in 
the treatment of AMD. Overexpression of HSPs can inhibit the accumulation of misfolded 
proteins as well as protein aggregates to the RPE cells and thus prevent the formation of 
drusen. Reduction of drusen formation may protect retinal function by preventing drusen-
associated inflammation. Additionally, drusen reduction may prevent hypoxia and nutrient 
deprivation in RPE by limiting the drusen-induced increase of diffusion distance between 
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choroid and RPE. However, in their review Virgili et al. [138] concluded that even though 
photocoagulation results in a reduction of drusen, there is no evidence that the removal of 
drusen reduces the risk of developing CNV, geographic atrophy or visual acuity loss.  
 
Besides its chaperone functions, HSPA is able to regulate several cellular processes. HSPA 
inhibits inflammatory response via prevention of activation of immune system regulator 
NFB [10]. Moreover, HSPA prevents apoptotic cell death by blocking caspase activation 
and thus promotes RPE cell survival and the normal functioning of RPE [11].  
 
Additionally, HSPA, with help from its co-chaperones, can aid the functioning of UPS. HSPA 
maintains misfolded proteins in the non-aggregated form to allow their degradation in the 
proteasome. In addition, HSPA helps ubiquitylation system to recognize misfolded proteins. 
After ubiquitylation, HSPA assists in the delivery of ubiquitinated protein to the 
proteasome. It is unknown what determines whether HSPA repairs the misfolded protein 
or promotes its degradation. [139] 
 
Besides mechanisms related to increased HSPA, other possible treatment mechanisms 
exist. These mechanisms include RPE regeneration, reduced angiogenesis, enhancement of 
cell defense systems against oxidative stress and prevention of Bruch’s membrane 
thickening. Laser treatment may have a regenerative effect on RPE. Vessey et al. [122], 
Zhang et al. [140], Jobling et al. [141] and Richert et al. [142] have observed that after RPE 
cell death-inducing laser treatment, new RPE cells are formed that repair the laser-induced 
lesion. They hypothesize that in response to laser treatment otherwise non-mitotic RPE 
cells regain their ability to divide and repair the laser-induced lesions with new cells. This 
would imply that RPE damaging laser treatment can replace the old and diseased RPE cells 
with new, younger cells and therefore, nanosecond laser therapy and SRT treatment are 
sometimes referred to as rejuvenating therapies. [113, 122]  
 
In addition, laser treatment can affect angiogenesis of the retina. Retinal reduction of 
proangiogenic VEGF and increase of antiangiogenic PEDF was observed after SRT in porcine 
choroid explants by Richert et al. [142] and after SDM in cultivated mouse RPE cells by Li et 
al. [143]. Li et al. [143] also observed that after SDM, proangiogenic factors transforming 
growth factor (TGF-) and basic fibroblast growth factor (bFGF) were downregulated in 
cultivated mouse RPE cells. These results indicate that laser treatment reduces 
angiogenesis and may thus prevent the formation of CNV. [143] Nevertheless, in studies 
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conducted by Cordeiro et al. [144] and Faby et al. [145] VEGF expression of ARPE-19 cells 
and isolated human RPE cells increased when they are exposed to elevated temperatures.  
 
Sublethal hyperthermia has been observed to enhance the cell defense system against 
oxidative stress. The ratio of reduced glutathione (GHS) to oxidized glutathione (GSSG) is 
often used as an indicator of oxidative stress. GHS is important antioxidant and its reaction 
with ROS generates GSSG. Cells recycle GSSG back to GHS. During oxidative stress, the ratio 
of GHS to GSSG decreases since a larger portion of GHS have reacted with ROS to produce 
GSSG. Iwami et al. [146] observed that hyperthermia-induced increase in GSH/GSSG ratio 
in cultivated porcine RPE cells. In addition, after H2O2 exposure, the hyperthermia 
preconditioned RPE cells showed less ROS induced toxic 4-hydroxynonenal (4-HNE) adducts 
which indicates that hyperthermia protected RPE cells against oxidative stress. [146] 
Increased GHS levels were observed also by Cillà et al. [147] in mice after laser treatment. 
Additionally, they observed increased levels of the antioxidant enzyme superoxide 
dismutase 1 (SOD1) and lowered levels of ROS induced lipid peroxidation end product 
malondialdehyde (MDA).  
 
Laser treatment may contribute to the prevention of Bruch’s membrane thickening by 
increasing the activity of Bruch’s membrane degrading MMPs. Changes in the amounts of 
activated MMPs have been observed after retinal laser treatment. Increase in active MMP 
after nanosecond laser treatment was observed in human RPE-choroid explants by Zhang 
et al. [140] and in AMD model mouse ApoE-/- by Jobling et al. [141] as well as after SRT in 
porcine RPE-choroid explants by Richert et al. [142] and Treumer et al. [148]. Bruch’s 
membrane thinning was observed after nanosecond laser treatment in ApoE-/- mice by 
Jobling et al. [141] as well as after SR-T in the AMD model mice ApoE-/- and NRF2-/- by Tode 
et al. [56]. It is not clear whether the MMP increase requires RPE cell death or not. Results 
of Treumer et al. [148] suggest that the MMP increase can only be triggered by RPE cell 
death or removal. However, Tode et al. [56] observed Bruch’s membrane thinning after TS-
R in ApoE-/- and NRF2-/- mice without significant changes in RPE cell structure.  
 
Bruch’s membrane thinning after laser treatment may also be related to increased HSPA 
expression. Sims et al. [149] observed that in breast cancer cell culture, depletion or 
inhibition of HSPA decreases MMP family member MMP-2 activation. Therefore, it is likely 
that HSPA has an important role in the activation of MMP-2. [149]  
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5.6.2.2 Retinal Temperature During Laser Treatment  
 
Elevated temperature damages retinal cells and can even lead to cell death. The extent of 
heat-induced cellular damage depends on the magnitude of the heat elevation as well as 
the duration of the temperature increase. [135] Therefore, the central goal in heat shock-
inducing retinal laser treatment is finding a combination of duration and magnitude of 
temperature increase that induces heat shock response expression but not cell death.  
 
Several studies have aimed to find out this therapeutic window: Kern et al. [135], Sramek 
et al. [132], Desmettre et al. [130, 131], Kim et al. [133], Lavinsky et al. [123] and Wang et 
al. [136, 150]. However, these studies lack a method to determine retinal temperature 
during laser treatment and have instead estimated temperature using mathematical 
models or compared the end-results of treatments conducted with different laser powers. 
This approach may prove problematic since temperature elevation during laser treatment 
is affected by various factors such as the amount of pigmentation, the distribution of 
pigmentation, the transparency of ocular media and blood flow [13, 14, 150]. Therefore, it 
is likely that heating with the same laser power does not yield the same retinal temperature 
in different patients and between different locations within the patient’s retina. 
 
One method for the estimation of thermal damage and HSPA expression is Arrhenius 
damage integral. Arrhenius damage integral assumes that the rate of protein denaturation 
caused by hyperthermia can be represented as a temperature-dependent chemical 
reaction. The value of Arrhenius integral is calculated as follows  
 
*
( )
0
( )
E
RT tA e dt



     (1) 
where A is rate coefficient, 
*E is activation energy, T is temperature and R is the gas 
constant. Arrhenius damage integral describes the amount of denaturation caused by 
temperature  T t  in time . The arrhenius damage integral model assumes that cell death 
occurs at a certain level of denaturation. [150] Sramek et al [151] found in rabbit RPE that 
the activation energy is * 340kJE
mol
  and that the rate coefficient is 55 11.6 10A s   
when the Arrhenius integral is normalized to 1    at the cell damage threshold. Sramek 
et al. [152] observed that in mouse the threshold of HSPA expression is  = 0.11. Therefore, 
non-damaging hyperthermia corresponds to Arrhenius integral values between 1 and 0.11. 
[152] Arrhenius damage integral model simplifies the thermal denaturation process in cells 
to a single reaction rate with one activation energy and assumes that there is no cellular 
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repair during hyperthermia [123, 150]. Despite this, the model can be used to determine 
damage and HSPA expression thresholds during short heating times. However, already with 
the pulse duration of 200 ms, the model becomes unreliable. [150] Therefore, other 
temperature estimation methods are required for longer heating durations.  
 
This Master’s thesis utilizes the ERG-based temperature determination method developed 
by Pitkänen et al. [15] to investigate the therapeutic window of subthreshold laser 
treatment. This method allows the assessment of retinal temperature during continuous 
laser heating treatments. The method is based on temperature-induced changes in the ERG 
signal and is described in more detail in [15]. 
 
The heating duration in this Master’s thesis was 10 minutes. HSPA expression in response 
to similar heating duration was studied by Barbe et al. [153]. They observed that raising the 
body temperature of rats to 41C for 15 minutes induced HSPA expression in the rat retina. 
Lower temperatures with longer exposure times up to 60 minutes did not result in 
increased HSPA expression. [153] Based on their results, it seems that 41C for 15 minutes 
corresponds to the lower limit of HSPA expression in the rat retina. In addition, HSPA 
expression was observed in the rat retina after 15 minutes of whole-body hyperthermia to 
41 - 42C by Tytell et al. [154]. Besides retina, the temperature of 42 - 42.2C for 15 to 20 
minutes has been used to induce increase HSPA expression in adult rat cardiomonocytes, 
rat heart and cortical cultures by Kawana et al. [155], Gowda et al. [156] and Rodolf et al. 
[157].  
 
Rylander et al. [158] studied HSPA expression in cultured bovine aortic endothelial cells. 
They searched for optimal heating protocol by testing several temperatures and heating 
durations. They observed that highest HSPA expressions were achieved with 44C, 46C, 
48C and 50C for 24 min, 12 min, 6 min, and 3 min, respectively. However, these 
treatments induced cell death. [158] Similar results were obtained by Kern et al. [135], who 
observed that in primary porcine RPE cultures the highest HSPA expression is achieved with 
heating that induces cell death. They calculated that cell death threshold is 50C and the 
threshold for occurrence of apoptotic changes is 47C when heating porcine RPE cell 
culture for 10 s. [135]  
 
The kinetics of HSPA expression were studied in rat optic nerve head after TTT by Kim et al. 
[133], in rat retina after the whole body hyperthermia by Tytell et al. [154] and in cultured 
choroid-retinal endothelial cells after laser irradiation by Du et al. [159]. Based on their 
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results, it seems that the peak of HSPA expression occurs around 18 hours after heating 
treatment and decreases thereafter. After 24 hours, the HSPA amount has moderately 
decreased but is still significantly higher compared to control. [133, 135, 159] After 48 
hours, Du et al. [159] observed HSPA levels similar to control. However, HSPA amounts 
above baseline level were observed after 48 hours by Kern et al. [135], after 50 hours by 
Tytel et al. [154] and after 72 hours by Kim et al. [133]. 
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6. Methods  
 
The purpose of this Master’s thesis was to study how laser heating treatment affects the 
retinal function in mice and to probe the therapeutic window of heat shock response in the 
laser heating treatment of RPE. During the experiments, retinas were subjected to different 
temperature elevations and we examined the effect of these temperature elevations on 
the retina. In order to reach the desired treatment temperature, ERG-based temperature 
assessment method was used during the heating treatment. We studied the effect of 
heating treatment to RPE using immunohistochemistry. RPE damage was assessed from 
the phalloidin staining of actin filaments that shows the cellular structure and increased 
amount of HSPA was used as an indicator for the heat shock response. This chapter 
describes the used methods. The chapter begins by introducing the theory of ERG-based 
temperature estimation and staining methods and continues with the detailed description 
of used methods. 
 
6.1 Electroretinography-Based Retinal Temperature Estimation 
 
Electroretinography (ERG) records changes in the electrical activity of the retina that are 
caused by light stimulation. It can be used to evaluate the retinal function and to diagnose 
various retinal disorders such as retinitis pigmentosa, congenital stationary night blindness, 
central retinal vein occlusion, central retinal artery occlusion, and retinal detachment. [160] 
ERG can be recorded from a living animal (in vivo ERG). Additionally, ERG can be recorded 
from an isolated retina or eyecup (ex vivo ERG). [17, 161]  
 
During darkness, retinal cells maintain extracellular ion currents, such as photoreceptor 
dark current. As stated by Ohm’s law, ion currents moving in resistive extracellular space 
create extracellular potential differences between the two sides of the retina. Combination 
of these potential differences created by different retinal cells constitutes the ERG signal. 
[17] Voltage during darkness is defined as a reference level in ERG recordings [162]. Light 
exposure changes extracellular ion currents and thus results in alterations in extracellular 
voltage [161].  For example, as described in Chapter 1.2.1, photoreceptor dark current 
reduces in response to light because of the closure of cGMP gated channels [19]. Due to 
the parallel organization of retinal cells, the radial currents sum up. However, the lateral 
arrangement of the retina is symmetrical and therefore lateral currents in retina mainly 
cancel each other. [161] 
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ERG signal is often divided into three components: P-I, P-II, P-III. These components are 
shown in Figure 12. P-I component is caused by pigment epithelium and P-II component by 
ON bipolar cells [163]. P-III component can be divided into fast P-III and slow P-III. Fast P-III 
component is caused by the activity of photoreceptor cells and slow P-III component by 
Muller cells. [161] Figure 13 shows ERG signal waveforms that are typically seen in the in 
vivo ERG signal of dark-adapted retina in response to light stimulus. The response starts 
with a negative a-wave. A-wave consists of fast P-III component and is partially overlapped 
by positive b-wave that is a summation of P-II and P-III components. B-wave is followed by 
c-wave that is mainly a summation of P-I and P-III components. [161] 
 
 
Figure 12. ERG signal recorded from cat eye in response to 2 s stimulus. P-I, P-II, and P-III 
components have been recorded by deepening the anesthesia. [161] 
 
 
Figure 13. ERG signal recorded from dark-adapted skate eye cup in response to stimulus 
lasting 0.2 s. Signal contains a-, b- and c-wave that are typically seen in in vivo ERG signal. 
[164, modified] 
55 
 
In this Master’s thesis, RPE heating was achieved by laser irradiation. Suitable laser power 
was selected using the ERG signal based temperature estimation method developed by 
Pitkänen et al. [15, 165]. They observed that temperature-dependent changes in ERG 
photoresponse kinetics and amplitudes can be used to estimate retinal temperature [15, 
165]. 
 
From heated RPE, heat spreads mainly by conduction to the rest of the retina. Ibarra et al. 
[13] found no significant difference between the temperatures of the inner limiting 
membrane and subretinal space in a rabbit during one-minute heating laser exposure. 
Therefore, temperature-induced changes in the ERG signal can be used to estimate RPE 
temperature during long heating treatments where the heat has a sufficient amount of 
time to dissipate from RPE to the rest of the retina. 
 
In this Master’s thesis, the temperature of the retina was estimated based on temperature 
dependent changes in the time from stimulus light pulse to ERG signal b-wave peak 
(referred in this Master’s thesis as time-to-maximum, TTM). Pitkänen et al. [15] showed 
that near mouse body temperature TTM decreases linearly with increasing temperature. 
They observed that the change of TTM compared to the body temperature is 3.6% per 1C 
for a mouse in vivo [15]. Temperature differences compared to body temperature T  were 
calculated using the equation 
 r ref
ref
TTM TTM
T B
TTM

     (2) 
where 
refTTM is the mean of reference TTM values measured in the body temperature, 
rTTM  is the recorded TTM and B  is a coefficient that describes the temperature 
dependence of TTM. For mouse in vivo, the coefficient B is -27.8 [15]. 
 
6.2 Immunohistochemistry 
 
Immunohistochemistry allows detection and localization of target molecules. The method 
is based on the interaction between antibody and antigen. [19] Antibodies or 
immunoglobulins are glycoproteins that are produced by the vertebrate immune system 
cells in response to a foreign substance. This foreign substance is referred to as antigen 
[166]. Antibodies have the ability to recognize and bind to the antigen as well as to the 
specialized cells and proteins of the immune system [167]. 
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Figure 14 shows a schematic presentation of the antibody structure. Antibodies have Y-
shape and they consist of four polypeptide chains: 2 heavy chains and 2 light chains. 
Antibodies are divided into five classes based on the structure of heavy chains. In mammals, 
types of heavy polypeptides are named alphabetically as α, δ, ε, γ and μ, and give rise to 
five classes of antibodies IgA, IgD, IgE, IgG, and IgM, respectively. The arms of Y are referred 
to as Fab domains and they contain a site that can bind to the specific part of antigen. This 
part of the antigen is referred to as an epitope or immunodeterminant region. The binding 
occurs via reversible, noncovalent interactions and therefore the antibody-antigen 
complex is in equilibrium with its free components. Antibodies are usually highly specific to 
one antigen. The base of the Y is referred to as the Fc domain and is important for the 
function and regulation of the immune system. [167] 
 
 
Figure 14. Schematic presentation of the antibody structure. [167] 
 
The specificity of an antibody refers to its ability to recognize certain antigen when other 
antigens are present. Affinity describes the binding strength of the antibody to antigen. 
Antibodies with higher affinity are preferable in immunochemical assays because they bind 
larger amounts of antigen with higher stability in a shorter time. [166] 
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Antibodies used in immunohistochemistry are produced in live animals by injecting a 
purified target molecule under the skin or into the bloodstream of the animal. The injected 
molecule initiates an immune response in the animal which causes the generation of 
antibodies. [19] Most antigens are highly complex and therefore, the immune system may 
produce several different antibodies that recognize different epitopes of the same antigen. 
Polyclonal antibodies are isolated from the serum of the animal and thus contain various 
antibody molecules that can bind to the same antigen. Production of monoclonal 
antibodies begins by isolating antibody-producing immune cells from the animal. Then, 
immune cells that produce the desired antigen are cultured and finally, the antigen is 
harvested from the culture. Monoclonal antibodies, therefore, bind to the same epitope. 
Polyclonal antibodies are more often used in the immunohistochemistry because they are 
not as sensitive to small changes in the antigen structure caused by polymorphism or 
denaturation. Polyclonal antibodies can also be produced more rapidly, at less expense and 
with less technical skill than monoclonal antibodies. [166] On the other hand, monoclonal 
antibodies have more homogenous specificities and affinities [167].  
 
Antibodies are attached to a label molecule that allows the detection of the bound antigen. 
Fluorophores are commonly used as label molecules in immunohistochemistry. 
Fluorophores are molecules that emit light when excited by light. [166] When the 
fluorophore molecule absorbs a photon, it receives energy and enters excited state. The 
excited state is short-lived and the fluorphore returns to its ground state by losing the 
excess energy. The excess energy can be lost as heat or by emitting photon. The wavelength 
of emitted light differs from the exciting wavelength when part of the energy has been lost 
as heat. This difference is referred to as the Stokes shift. Fluorophores can be detected with 
a fluorescence microscope. Fluorescence microscope illuminates the specimen with 
excitation wavelength light and separates emission light using filters. The emission light is 
then focused on the detector. [168]  
 
Figure 15 illustrates a direct and indirect method for antigen detection. In the direct 
method, the primary antibody attached to the marker molecule binds to the antigen. 
Similarly, in the indirect method, the primary antibody binds to the antigen but the marker 
molecule is attached to a secondary antibody that binds to the primary antibody. The 
indirect method allows amplification of the signal since multiple secondary antibodies can 
bind to the same primary antibody. [167] 
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Figure 15. Direct (left) and indirect (right) antigen detection [167] 
 
Immunohistochemistry staining protocols vary according to application. However, 
commonly used steps include tissue fixation, antigen retrieval, blocking, incubation with 
antibody, counterstaining and mounting. Prior to staining, the tissue is fixed to preserve its 
structure [169]. Formaldehyde is one of the most commonly used fixatives [170]. However, 
formaldehyde fixation may alter the structure of proteins reducing their detectability by 
immunohistochemistry. [171] One of these alterations is cross-linking of proteins by 
methylene bridges that mask the antibody binding sites [172]. The aim of antigen retrieval 
is to reverse these fixation-induced modifications in order to allow better detectability of 
the antigen. [171] Antigen retrieval can be achieved by using either protease digestion or 
heating. These methods are referred to as protease induced epitope retrieval (PIER) or 
heat-induced epitope retrieval (HIER).  
 
Blocking is done before the addition of primary antibody. The purpose of blocking is to 
prevent antibody binding to other proteins than the desired antigen. In blocking, a solution 
containing proteins, such as serum, is added to the tissue sample. These protein molecules 
bind to the sites that would otherwise potentially bind to the antibody thereby preventing 
or “blocking” antibody binding to other locations than the desired epitope. [170] 
Counterstaining can be used to make surrounding tissue morphology visible which aids in 
the localization of antigen [169]. After the staining is completed, the specimen is mounted 
between a slide and a cover-slip with mounting medium. The purpose of mounting medium 
is to physically protect the specimen by binding the specimen, slide, and coverslip together. 
[173] The stained specimen can then be imaged using a fluorescence microscope. 
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6.3 Retinal Heating Experiments 
 
The recording protocol and the equipment were developed in the Department of 
Neuroscience and Biomedical Engineering (NBE) of Aalto University. The used equipment 
is described in more detail in the Master’s thesis by Kaikkonen [174]. The used retinal 
temperature estimation method is developed by Pitkänen et al. [15]. 
 
6.3.1 Animals and Preparation 
 
The use and handling of the animals were in accordance with the Finnish Act on Animal 
Experimentation 2006 and the guidelines of the Animal Experiment Board in Finland. The 
project plan has been approved by the Finnish Animal Experiment Board (project license 
number: ESAVI/6345/04.10.07/2015). 
 
Female mice of age 4-5.5 months of strain C57BL/6JRccHsd were used in the experiments. 
This age group was selected because the mice of this age are mature but not yet affected 
by senescence [175]. The mice were kept in a 12:12 light/dark rhythm and dark-adapted 
overnight before the experiment day. The mouse was placed in an induction chamber and 
anesthetized using inhalation of isoflurane (Animalcare Ltd. York, UK). The induction 
concentration of isoflurane was approximately 4.5 % and maintenance 1.1 % in 100 % 
oxygen. Righting reflex was tested by tipping the induction chamber over. After losing 
righting reflex, the animal was placed on a custom-made polycarbonate bed equipped with 
anesthetic supply. All handlings were done under dim red light. 
 
In order to prevent the movement of the eye during heating, 0.5 mg/kg of medetomidine 
(Orion Corporation Orion Pharma, Espoo, Finland) diluted in 9 mg/ml NaCl solution 
(B.Braun, Melsungen, Germany) was injected subcutaneously. During anesthesia, 
respiration was monitored using piezo electrode (Pico Movement Sensor, MFi BV, Heerlen, 
The Netherlands) that was placed underneath the mouse slightly behind the thoracic 
diaphragm. Isoflurane concentration was adjusted during the experiment to maintain 
respiration rate 2-2.5 Hz. The body temperature was measured by a rectal thermistor 
(Betatherm 30K6A309I, Oy Farnell Finland Ab, Helsinki, Finland). Appropriate body 
temperature was maintained by adjusting the temperature of the water circulation inside 
a polycarbonate bed, underneath the mouse.  
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The pupil of the right eye was dilated using 10 mg/ml atropine sulfate eyedrop (Bausch + 
Lomb UK Ltd., London, UK) and 100 mg/ml phenylephrine HCl eyedrop (Bausch + Lomb UK 
Ltd., London, UK). The corneas of both eyes were anesthetized using 4 mg/ml 
oxybuprocaine HCl eye drops (Santen Ltd., Tampere, Finland). Eyes where moisturized 
using 6 mg/ml methylcellulose (Yliopiston Apteekki, Helsinki, Finland) in 9 mg/ml NaCl 
solution (B.Braun, Melsungen, Germany) 
 
Figure 16 presents the restraining of the mouse and the position of the electrodes. The 
position of the mouse was fixed using ear holders and a rubber band that was placed over 
the mouse’s forehead. Whiskers of the mouse were cut to prevent them from disturbing 
the contact between electrodes and eyes. The electrodes were Ag-AgCl pellet electrodes 
(ground and recording electrodes: EP1, reference electrode: EP2, World Precision 
Instruments Ltd., Hitchin, UK). The reference electrode was placed inside a holder made of 
1 ml syringe. The syringe was filled with the methylcellulose solution to provide contact 
between the eye and electrode and the tip was placed around the left eye. The ground 
electrode was moisturized with the methylcellulose solution and placed in the rectum of 
the mouse. 
 
Figure 17 presents the placement of the recording electrode and the fundus lens. The 
measurement electrode was placed in a custom made holder filled with the 
methylcellulose solution. The electrode holder has a glass capillary tip that allows electrical 
contact between the electrode and the eye. This tip was placed next to the fundus lens of 
the heating device and the fundus lens was brought in contact with the methylcellulose 
solution on the right eye of the mouse. The fundus lens was placed using monochrome 
video camera imaging through the fundus lens. During the placement of the fundus lens, 
the mouse eye was illuminated by infrared light and by heating laser light with low power 
setting. After lens placement, a small amount of methylcellulose solution was added to the 
eye through the glass capillary tip to ensure proper moisturization of the eye and electrical 
contact between the eye and measurement electrode. The heating laser spot was placed 
approximately in the center of the dilated pupil. 
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Figure 16. Restraining of the mouse and the position of electrodes. 
 
 
Figure 17. Placement of recording electrode and fundus lens. [174, modified] 
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6.3.2 Heating Treatment 
 
In this Master’s thesis, the temperature-dependent changes in ERG-signal were used to 
estimate mouse retinal temperature during laser-induced retinal heating. The potential 
difference was recorded between the electrode placed in contact with the eye and the 
grounding electrode placed to the rectum of the mouse. The potential difference was 
recorded simultaneously from both of the eyes. The right eye was stimulated with short 
light pulses and heated with infrared light whereas the left eye acted as a reference. 
Studied ERG signal was obtained by subtracting the potential difference measured from 
the left eye from potential difference measured from the right eye. The difference of 
potential differences during darkness was defined as a baseline level and set to zero.  
 
Light stimuli were generated using two diode lasers with wavelengths 515 nm (LD-520-
120MG, 120 mW, Roithner Lasertechnik GmbH, Vienna, Austria) and 785 nm (RLT780-
1000G, 1W, Roithner Lasertechnik GmbH, Vienna, Austria) referred in this Master’s thesis 
as green and near-infrared laser. The intensity of stimuli was not changed during the 
experiment. Instead, stimulus strength was adjusted by changing the stimulus duration, 
maximum stimulus duration being 2 ms. These stimuli lengths are short enough to be 
perceived as impulse-like stimuli by the rod cells [176]. The DC-ERG signals were amplified 
1000-fold, low-pass filtered with eight-pole Bessel filter (cutoff frequency 1 kHz) and 
digitized at 5 kHz with 30 nV resolution. 
 
Heating was conducted using a diode laser (RLCO-1064-2000-TO3, 2 W, Roithner 
Lasertechnik GmbH, Vienna, Austria) with a wavelength of 1064 nm. This wavelength of 
light does not induce significant light adaptation of mouse rod cells in the laser power used 
in these experiments [174]. Figure 18 presents the power density profile of the heating 
laser beam. The approximate diameter of the heating laser spot on the retina was 0.8 mm 
and the diameter of stimulus laser spot was 0.5 mm [174].   
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Figure 18. Heating laser beam power density profile. The black and green line represent 
power density in the direction of x-axis and y-axis, respectively. The center of the heating 
laser beam is at zero position.  
 
ERG stimulus strengths were selected for each mouse based on their individual ERG-
responsiveness. For each mouse, a stimulus strength was found that yielded an ERG signal 
with an a-wave amplitude of  30-50 V. From this signal, the difference between the b-
wave peak and the a-wave peak was calculated. In this Master’s thesis, this value is referred 
to as peak-to-peak amplitude.  
 
The peak-to-peak amplitude was utilized to determine stimulus strengths used during the 
experiment. ERG-signals were recorded in response to near-infrared as well as green laser 
stimuli to allow study the of long-wavelength relative sensitivity described by Pitkänen et 
al. [165] (analysis not included in this Master’s thesis). Stimulus strengths were selected to 
result in the b-wave amplitude of 40 % of the peak-to-peak amplitude separately for the 
light sources. Additionally, a small number of responses to stronger stimuli were recorded. 
These stimuli are referred to in this Master’s thesis as strong stimuli in contrast to shorter 
lasting dim stimuli. Strong stimuli were only recorded using the green laser. Strong stimulus 
duration was equal to 400 times the duration of a dim green stimulus. In this Master’s 
thesis, only ERG responses recorded in response to dim stimuli were analyzed.  
 
During the experiment, dim flash responses were recorded repetitively. Green and near-
infrared dim flashes alternated. In addition, strong flash responses were recorded 
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sporadically. The interval between dim flashes was 3.5 s and after strong flash, no 
additional flashes were given for 20 s to allow photoreceptor cells to return to their dark-
adapted state [15]. 
 
After the placement of the lens, the mouse was let to dark-adapt for 12 minutes without 
exposure to the dim red light that was used during the preparations. Suitable light stimuli 
strengths were searched during the dark-adaptation period. Heating treatment started 
after the dark-adaptation. In this Master’s thesis, the retinal temperature was determined 
from the change in the b-wave time-to-maximum (TTM) compared to the TTM values 
recorded in the body temperature. After dark-adaptation, ERG signals that were used as a 
reference in the temperature estimation were recorded at the body temperature. During 
the experiment, 20 or more ERG responses were recorded for the reference. From 
reference ERG responses, an average of TTM was calculated and set as a reference level to 
which later determined TTM values were compared in order to estimate retinal 
temperature changes. After the recording of reference, the representativeness of this 
reference was confirmed by recording further ERG responses in the body temperature and 
comparing the temperature estimate based on these responses to the temperature 
recorded from the rectum of the mouse. Mouse body temperature during the recording of 
reference was 37.1 - 37.5 C. 
 
After finding an acceptable reference, heating was initiated. Heating consisted of two parts 
referred in this Master’s thesis as pre-heating and treatment heating. In pre-heating, the 
retina was heated to 41  0.3 C. The heating laser power needed to arrive at the pre-
heating temperature was searched by testing different power settings starting from the 
small power values. The duration of this search varied from 2 minutes to 5 minutes. When 
a suitable heating power was found, the treatment heating phase was initiated by 
multiplying the power needed to reach the pre-heating temperature with a predefined 
factor. Three factors were used in this Master’s thesis: 2, 2.5 and 3. This two-phase method 
was used because the temperature estimation method was calibrated by Pitkänen et al. 
[15] up to 42.5C and the method’s capability of estimating temperature above this point 
was unknown. The retina was heated with the treatment power for 10 minutes. After this, 
the heating laser was turned off and ERG responses were recorded for a couple of minutes. 
Figure 19 providing an example of the heating laser power and estimated retinal 
temperature during the different stages of the experiment is presented in Chapter 7.1. 
 
During the experiment, the room air temperature was elevated so that the difference in 
the temperatures of air around the mouse and the water circulating beneath the mouse 
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was no more than 4 C. Therefore, it was assumed that the temperature measured by rectal 
thermistor matches the temperature of the retina when the retina is not heated. The 
temperature of the water circulation underneath the mouse and air around the mouse 
were not adjusted during the heating.  
 
6.3.3 Animal Recovery 
 
After the heating treatment, electrodes were detached, the rectal thermistor was removed 
and the mouse was released from the ear holders and rubber band. 0.25 mg/kg of 
medetomidine reversal atipamezole (Orion Corporation Orion Pharma, Espoo, Finland) was 
injected subcutaneously. Isoflurane administration was terminated and the mouse was 
placed in a clean and empty cage with a pre-heated bottom. The mouse was moved to a 
quieter room to recover. Electric heating pad (Beurer GmbH. Ulm, Germany) was placed 
underneath the cage and the temperature of the pad was adjusted to maintain appropriate 
body temperature. Moisturized, soft food was available for the mouse. Approximately one 
hour after the end of isoflurane administration, bedding, nest material, and solid food were 
added to the cage. The mouse was transferred to the animal room for the night and the 
cage was partially placed on a heating pad (Braintree Scientific, Inc. Braintree, 
Massachusetts, United States) in order to help the mouse to maintain appropriate body 
temperature. 
 
6.4 Histological analysis 
 
Immunostaining protocol developed by André et al. [177] was modified by Mooud 
Amirkavei to be applicable to this study. Staining and imaging were performed by Mooud 
Amirkavei. 
 
Mice were euthanized 24 hours after heating treatment by inhalation of CO2 and cervical 
dislocation. The eyes were removed and eyecups isolated. Posterior eyecups containing 
RPE, choroid, and sclera were dissected from the surrounding tissues.  
 
Tissue samples were fixed for 10 minutes at room temperature in 4% formaldehyde 
solution (FA; Solveco, Rosersberg, Sweden) in phosphate-buffered saline (PBS) (Gibco, 
Paisley, UK). Tissue fixation was followed by washing of the sample with PBS. Antigen 
retrieval was accomplished by microwave heating for 3 minutes in Diva Decloaker (Biocare 
Medical, Concord, CA, USA) diluted to 1:10. After antigen retrieval, samples were incubated 
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for 1 hour at room temperature in blocking solution that consisted of 10% normal goat 
serum (Invitrogen, Camarillo, MD, USA) in PBS containing 0.1% Triton X-100 (Sigma-Aldrich 
Corp., St. Louis, MO, USA). After blocking, the sample was incubated in primary antibody 
overnight at 4C. The used primary antibody was HSP70/HSP72 monoclonal antibody 
(Santa Cruz Biotechnology, Paso Robles, CA, USA) diluted to 1:50. The secondary antibody 
was anti-rabbit A594 (Invitrogen, Camarillo, MD, USA) that was diluted to 1:500. For 
counter-staining, Hoechst 33258 (5 g/L in PBS; Sigma-Aldrich Corp.) diluted to 1:2000 and 
Phalloidin A488 (Invitrogen, Camarillo, MD, USA) diluted to 1:2000 were added to the 
secondary antibody. The secondary antibody was incubated for one hour at room 
temperature. Antibody dilutions were performed in blocking solution. After each antibody 
step, the tissue sample was washed with PBS. Tissue was post-fixed for 10 minutes at room 
temperature in 4% formaldehyde solution in PBS after which the sample was flat-mounted 
with fluorescent mounting medium (Dako, Carpinteria, CA, USA). Images were acquired 
with Axioimage fluorescence microscope with the Zen software (Zeiss, Gottingen, 
Germany).  
 
6.5 Data Analysis 
 
The analysis of ERG responses was performed in Matlab 2018b and 2014b (MathWorks) 
and in Microsoft Excel 2013. Periodical artifacts, such as artifacts caused by the mouse’s 
breathing, were removed from the signal using an autoregressive model of order 2500 [15]. 
This model predicted the baseline behavior after the stimulus based on the baseline 
behavior before the stimulus. The predicted baseline behavior was subtracted from the 
recorded signal to yield the final ERG signal.  
 
The peak of b-wave was located from the dim responses by fitting quadratic polynomial 
around the global maximum. Correction of the fitting was obtained by repeating the fitting 
around the peak obtained from the first fit. TTM was defined as the maximum of the second 
fit.  
 
Analyzed ERG responses were assigned to a category depending on which phase of the 
experiment they were recorded.  The reference category contained the ERG responses 
used as a reference during the experiment and the responses that were used during the 
experiment to confirm the representativeness of selected reference. The pre-heating 
category contained ten last ERG responses before the multiplication of the heating laser 
power with the selected treatment factor. The treatment heating category contained all 
the ERG responses where treatment heating laser power was used except for ten first 
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responses. The after category contained responses recorded after the heating laser power 
was switched off at the end of the experiment excluding 20 first responses.   
 
The autoregressive model was unable to remove artifacts with unfixed interval. Incomplete 
artifact removal and random response noise resulted in variation in TTM. Within each 
category, inter-quartile range method (IQR-method) was used to find potential outliers of 
TTM values. The inter-quartile range is defined as an interval between the 25th percentile 
and 75th percentile of the data. The method defines recorded TTM values outside the 
range -1.5 * IQR and 1.5 * IQR are defined as possible outliers and values outside the range 
-3 * IQR and 3 * IQR as probable outliers. [178] The outliers were confirmed by visual 
inspection before excluding them from the analysis. The temperature of the retina was 
estimated based on temperature dependent changes in the TTM values using a method 
that was described in Chapter 6.1.  
 
Analysis of the fluorescence microscope images was done using Zeiss Zen Lite Blue 2.6. The 
mean HSPA intensity values were calculated from the whole flat-mounted tissue area of 
the control eye and heated eye by approximately selecting the tissue area from the images 
and calculating mean of pixel brightness values of that area. Lesion diameter was measured 
by approximately fitting circle to the lesion images. Statistical analysis was conducted using 
Microsoft Excel 2013 and figures were drawn by Microsoft Excel 2013 and Matlab 2014b 
(MathWorks). 
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7. Results 
 
7.1 Stages of the Experiment 
 
Figure 19 demonstrates the different stages of heating treatment experiments. Figure 19 
A illustrates the laser power during the treatment and Figure 19  B the subsequent 
temperature elevation in the retina estimated based on the temperature dependent 
changes in ERG time-to-maximum (see Chapter 6.1). The experiment starts with the 
recording of reference responses at body temperature without heating laser exposure and 
the temperature estimation begins after collecting the first reference set. The 
representativeness of the reference is confirmed by recording an additional set of 
reference responses at body temperature and comparing estimated retinal temperature to 
the body temperature measured by a rectal thermistor. In the experiment presented by 
Figure 19 B, the estimated temperature increase compared to the body temperature 
before heating laser onset is approximately zero indicating that the selected reference was 
representative. The reference collection is followed by the pre-heating phase where 
heating laser power is adjusted to induce retinal heating to 41C. This corresponds to the 
temperature increase of approximately 4C in Figure 19 B. When 41C is reached, the used 
heating laser power is multiplied with the selected treatment factor to induce the 
treatment heating. After 10 minutes of treatment heating, the laser is turned off and retinal 
temperature returns approximately to the initial level as demonstrated in Figure 19 B. 
Additionally, Figure 19 B presents a small, gradual decrease in the estimated retinal 
temperature during treatment heating that was observed in some of the experiments. 
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Figure 19. The different stages of heating treatment experiment with treatment factor of 
3. A. Heating laser power during experiment B. Estimated retinal temperature increase 
compared to body temperature during the experiment. Data in figures A and B are 
recorded from one mouse during one heat treatment. In the beginning and end of the 
experiment, the heating laser power deviates from zero due to calibration error.  
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Figure 20 shows ERG responses to a dim green stimulus at the different stages of the 
experiment. The presented responses are non-averaged green stimulus responses and are 
filtered with a low pass FIR filter (Hamming window, n = 400, fc = 30 Hz).  Figure 20 
demonstrates how the kinetics of ERG response accelerate as the retinal temperature 
increases and that the response kinetics return approximately to the initial level after the 
heating laser is turned off. Additionally, Figure 20 shows a time-dependent amplitude 
decrease that we usually observed during the experiments. 
 
Figure 20. ERG responses from different experiment stages. Responses are single 
responses recorded using a dim flash response and filtered with a low pass FIR filter 
(Hamming window, n = 400, fc = 30 Hz).  
 
7.2 Power in the Pre-Heating Phase 
 
We investigated the relationship between the heating laser power and the estimated 
retinal temperature in different mice at the pre-heating phase where the retina was heated 
to 41  0.3 C. Suitable heating laser power was searched by testing different power 
settings starting from low power values. Figure 21 shows the estimated retinal temperature 
increase in the pre-heating phase as a function of the heating device power. 
 
71 
 
Figure 21 demonstrates that the power needed to reach the target temperature varied 
substantially between experiments. Two experiments shown in Figure 21 were rejected 
from the analysis due to excessively high temperature during the pre-heating phase and 
unreliableness of the temperature estimation caused by a large artifact superimposed to 
the ERG signal from mouse breathing. Without these experiments, the mean temperature 
increase during the pre-heating phase was 3.8  0.2 C and heating laser power was 48.1  
10.3 mW (presented as mean  standard deviation (STD)).  
 
Figure 21. The temperature increase in the pre-heating phase compared to body 
temperature as a function of heating laser power in 16 mice. Each data point represents 
the mean of estimated temperature increase determined from ten last ERG responses in 
the pre-heating phase in one mouse when the temperature had stabilized. Only minor 
adjustments to the heating laser power were done during this time. Error bars present 
standard deviation. 
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7.3 Temperature Estimate During Heating Treatment 
 
The aim of this Master’s thesis was to study the effect of three different treatment 
temperatures on retinal HSPA expression and RPE cell structure. These temperatures were 
achieved by multiplying the heating laser power of the pre-heating phase with three 
different treatment factors (2, 2.5 or 3). However, we observed using one-way analysis of 
variance that this method did not result in a statistically significant difference in used 
heating laser power (p-value 0.33) or estimated temperatures (p-value: 0.08) during 
heating treatment. In addition to the experiments rejected in the analysis of the pre-
heating phase, one experiment was rejected from the analysis because of unreliableness 
of temperature estimation at the heating phase that was caused by a large artifact 
superimposed to the ERG signal from mouse breathing. 
 
Figure 22 A presents boxplots of the heating laser power during the treatment heating in 
each treatment group. Figure 22 B illustrates the estimated treatment heating 
temperatures in each treatment group. It is noteworthy that the estimated median 
temperature elevation compared to the body temperature in a group treated with 
treatment factor 2.5 was lower than in a group with treatment factor 2 (Figure 22 B), even 
though the median heating laser power was higher (Figure 22 A). Figure 23 shows the 
estimated temperature increase in the pre-heating phase and in the treatment heating 
phase as a function of heating laser power. The relation of the temperature increase and 
the heating laser power was non-linear. 
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Figure 22.  Boxplots of (A) heating laser power and (B) estimated retinal temperature 
increase compared to the body temperature during heating treatment phase when using 
three different heating treatment factors. The number of experiments for factor 2 is 3, for 
factor 2.5 is 4 and for factor 3 is 6. 
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Figure 23. The estimated temperature increase in the pre-heating phase and in the 
treatment heating phase compared to the body temperature as a function of the heating 
laser power. The figure presents data of 13 mice. From each mouse, two data points were 
obtained: one from the pre-heating phase (temperature increase approximately 4 C) and 
one from treatment heating phase (temperature increase approximately 5-6.5 C). The 
fitted curve is determined using the least-squares method. Since, at zero heating power, 
the retinal temperature is assumed to correspond to the body temperature, the fitted 
curve is forced through the origin.  
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7.4 HSPA Expression and Cell Structure 
 
Figures 24, 25 and 26 show example fluorescence microscope images of the flat-mounted 
RPEs of the control eye (A) and treated eye (B) obtained using treatment factors 2, 2.5 and 
3, respectively. In these figures, the arrow indicates the location of the optic disk. The right 
eye of the mouse was always treated and the left eye acted as a control. HSPA is constantly 
expressed in cells and is therefore present also in the control eye. Larger versions of Figures 
24, 25 and 26 are presented in the Appendix. 
 
 
Figure 24. Images of stained and flat-mounted RPEs after heating with treatment factor 2. 
Arrow indicates the location of the optic disk. A. HSPA staining of the control eye. B. HSPA 
staining of the treated eye. C. Close-up image of the heated area. Image borders are 
indicated with a dashed rectangle in Figure 24 B. D. Phalloidin staining of the center of the 
heated area. The location of the white dot is the same in Figures 24 C. and 24 D.  
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Figure 25. Images of stained and flat-mounted RPEs after heating with treatment factor 
2.5. Arrow indicates the location of the optic disk. A. HSPA staining of the control eye. B. 
HSPA staining of the treated eye. C. Close-up image of the heated area. Image borders are 
indicated with a dashed rectangle in Figure 25 B. D. Phalloidin staining of the center of the 
heated area. The brighter area at the center of the figure is probably neural retina that 
was not properly removed during dissection. The location of the white dot is the same in 
Figures 25 C. and 25 D.  
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Figure 26. Images of stained and flat-mounted RPEs after heating with treatment factor 3. 
Arrow indicates the location of the optic disk. A. HSPA staining of the control eye. B. HSPA 
staining of the treated eye. C. Close-up image of the heated area. Image borders are 
indicated with a dashed rectangle in Figure 26 B. D. Phalloidin staining of the center of the 
heated area. The location of the white dot is the same in Figures 26 C. and 26 D. 
 
In order to find out whether the heating treatment increased the overall HSPA expression 
in the treated retina compared to the non-treated control retina, we calculated the mean 
HSPA intensity values from the whole flat-mounted tissue area. Table 2 presents the 
descriptive statistics of the collected data. The number of imaged tissue samples was 
smaller than the number of heating treatments due to unsuccessful staining or recovery 
from anesthesia. Additionally, one experiment with factor 2.5 was excluded from the 
intensity analysis due to inappropriate staining. We used a one-tailed paired t-test to assess 
whether there is a statistically significant difference in HSPA intensity values between 
78 
 
control and treated eye. We found a statistically significant increase in the HSPA intensity 
compared to the control eye when using treatment factor 3 (p-value: 0.003). 
 
Table 2. Descriptive statistics of mean HSPA intensity values measured from the flat-
mounts of the control eye and heated eye and expressed as average  standard error of 
the mean (SEM). P-values of the one-tailed paired t-test are marked with * when the 
result is statistically significant using significance level 0.05.  
Treatment factor Control Heated P-value N 
3 3 267 ± 1 130 7 396 ± 1 637 0.003 ** 4 
2.5 7 633 ± 1 862 13 335 ± 5 061 0.163 2 
2 6 809 ± 2 068 8 327 ± 3 719 0.256 3 
 
Additionally, we studied the mean flat-mount HSPA intensity of the treated eye relative to 
the control eye between the different treatment factors. Figure 27 shows a boxplot of the 
relative HSPA intensity in different treatment factors. We identified with one-way analysis 
of variance that there is a statistically significant difference between relative HSPA intensity 
(p-value: 0.035). Post hoc analysis using one-tailed two-sample t-test revealed statistically 
significant differences between treatment factor 3 compared to treatment factor 2 (p-
value: 0.009). We found no statistically significant difference between treatment factors 3 
and 2.5 (p-value: 0.051) and between treatment factors 2.5 and 2 (p-value: 0.106).  
 
Figure 28 presents the relative HSPA flat-mount intensity between control and treated the 
eye as a function of heating laser power. We found a strong correlation between the 
relative HSPA intensity and the heating laser power (Pearson correlation coefficient: 0.85). 
Additionally, we found a strong correlation between the relative HSPA intensity and the 
treatment factor (Pearson correlation coefficient: 0.81). Using the statistical test described 
by Steiger [179] we determined that the difference of these correlation coefficients is not 
statistically significant (p-value: 0.826).  
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Figure 27. Boxplot of the relative HSPA intensity in the treated eye recorded after heating 
with treatment factors 2, 2.5 and 3.  
 
 
Figure 28. The relative HSPA flat-mount intensity of the treated eye as a function of 
heating laser power. The trend line is determined using the least-squares method. 
Treatment factors were 2 (blue square), 2.5 (grey diamond) and 3 (red circle). 
80 
 
Figures 24 B, 25 B and 26 B show a distinct, approximately a circular area near the optic 
disk where HSPA intensity is low. Furthermore, this low HSPA intensity area is surrounded 
by a ring of brighter HSPA intensity. This HSPA expression pattern is assumed to be located 
within the heated area since it can be identified in the majority of treated eyes and a similar 
area is not visible in the control eyes. Figures 24 C, 25 C and 26 C show close-up images of 
this area with different treatment factors. 
 
We studied the effect of treatment factor on the diameter of the low HSPA expression area. 
The diameter was determined as the diameter of a circle that was fitted to the edges of the 
low HSPA expression area in the fluorescence microscope images of HSPA staining. The 
analysis was conducted for the tissue samples from which we were able to determine the 
low HSPA expression area diameter. Treatment factor 2 was not included in this analysis 
due to difficulties in determination of the diameter. The low HSPA expression area 
diameter in tissues treated with factor 3 was 472  31 and in tissues treated with factor 2.5 
was 505  153 (expressed as average  standard error of the mean (SEM)). We performed 
a one-tailed two-sample t-test to analyze the statistical significance of the treatment 
factors 3 and 2.5 on the diameter of the low HSPA expression area. According to this t-test, 
there was no statistically significant difference in lesion size between treatment factors 3 
(N = 3) and 2.5 (N = 3) (p-value: 0.424). The overall average lesion diameter in these 
treatments was 488  70 m (presented as average  SEM) corresponding to roughly 60 % 
of the approximated diameter of the heated area.  
 
Figures 24 D, 25 D, and 26 D illustrate phalloidin staining of the heated area where the 
location of the white dot is the same as in Figure 24 C, 25 C, and 26 C, respectively, and 
where the arrow indicates the location of the optic disk. The edges of the concerned area 
show a normal, hexagonal RPE cell structure where the cells are presumably intact. 
However, we observed abnormal RPE cell structure in the center of the heated area 
indicating cell death. The abnormal RPE cell structure in the middle of the heated area 
appeared in the majority of tissue samples independent of the treatment factor.  
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8. Discussion 
 
The purpose of this Master’s thesis was to study how laser heating treatment affects the 
retinal function in mice. The aim was to collect information for ongoing research developing 
a subthreshold heating treatment protocol that induces heat shock without causing cell 
death in the retina. The heating treatment protocol was evaluated by studying the effect 
of treatment on the HSPA expression and cell structure of RPE cells. In addition, the 
necessity of usage of temperature determination method during heating treatment and 
the suitability of ERG based temperature estimation method were assessed by studying the 
relationships between the estimated retinal temperature increase, the heating laser 
power, and the observed effect in the immunostaining of the RPE. This chapter discusses 
the results obtained in this Master’s thesis. 
 
8.1 Variation in Heating Laser Power 
 
It was found that in different mice, different heating laser power was needed to reach the 
same retinal temperature elevation. Possible reasons for this variation include both 
interindividual and intraindividual differences in fundus pigmentation, choroidal blood 
flow, and cataract formation during the experiment.  
 
Contribution of topographical and interindividual pigmentation differences on the needed 
laser power is supported by previous research. Topographical differences in RPE 
melanosome content have been observed in mice by Williams et al. [180] and in rats by 
Howell et al. [181]. They both conclude that melanosome content is lower in the superior 
RPE compared to the inferior RPE. Additionally, Howell et al. [181] found that melanosome 
content was lower in the central RPE compared to the peripheral RPE.  In addition to 
rodents, topographical differences have been found in humans. Gabel et al. [182] observed 
that in humans absorption of light by RPE and choroid depends on the location of the retina 
and varies up to a factor of 4 between individuals. Also, Schmidt et al. [26] found 
topographical alterations in the melanin concentration of human retina. They observed 
that in humans melanin concentration is the lowest in the area around the macula, higher 
in mid-periphery and the highest in the far periphery. [26] In addition, Schmidt et al. [26] 
and Sarna et al. [183] observed that in human RPE the melanin concentration decreases 
with age. However, this decrease does not include the macular area [26]. Furthermore, 
additional variation to the fundus pigmentation is induced by choroidal blood vessels that 
cause a local decrease in choroidal pigmentation [184]. Therefore, it seems plausible that 
variation in pigmentation is an important factor causing interindividual and intraindividual 
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differences in laser power needed to reach a specific retinal temperature during laser 
treatment. This needs to be taken into consideration when developing laser heating 
treatment methods.   
 
Besides pigmentation, variation in perfusion and choroidal vasculature may contribute to 
the observed variation. Herrmann et al. [12] observed in a rabbit that when heating lasts 
several seconds or more, choroidal perfusion has a considerable cooling effect on retinal 
temperature. Mathematical model by Kandulla et al. [14] indicates that perfusion lowers 
the temperature increase within heating laser spot but steepens the temperature gradient 
at the border of the heating laser spot. Therefore, interindividual differences in choroidal 
perfusion and vasculature may induce variations in the resulting retinal temperature and 
temperature profile during heating treatment. In addition, spatial variation in perfusion 
within the retina can cause differences in the resulting temperatures. During the 
treatment, areas of high-temperature increases might occur in locations where choroidal 
perfusion is low. However, also too small temperature increases may occur in areas above 
main vessels where perfusion is high. In addition to the vasculature, the perfusion rate 
depends on the intraocular pressure [12]. Herrmann et al. [12] were able to increase the 
temperature elevation of laser irradiated retina by increasing intraocular pressure. This 
could explain some of the observed variation since, in some of the experiments during the 
laser treatment, the fundus lens may have pressed against the eye increasing the 
intraocular pressure.  
 
Additionally, the transparency of ocular media affects the laser-induced temperature 
increase of the retina [150]. The transparency can be reduced by conditions such as 
cataract. Cataract formation is frequently observed in rodents during anesthesia. Rodent 
cataract formation during anesthesia is hypothesized to be caused by drying of the corneal 
surface, lowered body temperature, hypertonic osmolarity, and anesthetics. [185] Cataract 
formation was observed in all of the experiments of this Master’s thesis and the amount of 
cataract increased gradually during each experiment.  
 
Due to multiple reasons affecting the laser-induced retinal temperature elevation during 
the heating treatment, it is not reasonable to treat all mice and all parts of the retina with 
the same heating laser power. This is also supported by our finding that the laser power 
needed to reach the temperature of 41  0.3 C varies substantially between the mice. 
Furthermore, the observed variance in heating laser power needed to reach the pre-
heating temperature may be more prominent in human patients compared to inbred 
C57BL/6JRccHsd mice that have a practically identical genome. Therefore, in order to 
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facilitate sub-threshold heating treatment, a reliable real-time temperature determination 
method needs to be used during the treatment. 
 
8.2 Doughnut Shaped HSPA Pattern  
 
In the immunohistological analysis, we observed a doughnut-shaped HSPA pattern where 
HSPA intensity was the highest in a circular area surrounding an area with low HSPA 
expression. Similar HSPA pattern has been observed in porcine cell cultures by Kern et al. 
[135], in rabbit by Lavinsky et al. [123] and in rabbit by Wang et al. [136]. Consistent with 
our results, all these groups observed RPE tissue damage in the dark middle area. In 
addition, they observed that with lower heating power, the dark area was missing and 
heating induced a disc of elevated HSPA expression. [123, 135, 136] 
 
In this Master’s thesis, we used a roughly top hat-shaped heating laser beam. For heating 
treatments lasting less than 1 ms, top hat-shaped heating laser beam induces nearly 
uniform radial temperature distribution within the laser spot [186]. However, when heating 
laser pulse lasts longer, as was in the experiments of this Master’s thesis, the temperature 
profile resembles a bell curve where the temperature in the middle of the beam is higher 
than at the edges [14, 187]. This may explain the observed doughnut pattern. Figure 29 A 
illustrates a hypothesis on how the bell curve-shaped temperature profile could induce a 
doughnut-shaped HSPA expression. Near the center of the laser, spot cells are subjected to 
lethal temperatures. Dead cells do not produce HSP and consequently, the center of the 
spot is seen as a dark area in fluorescent microscope images. Further away from the center 
of the heating spot, the induced temperature is not lethal but is high enough to induce 
HSPA expression that is observed in the staining images as a bright ring around the dark 
center of the laser spot. Near the edges of the laser beam, the temperature is close to body 
temperature and is not sufficient to induce an increase in HSPA expression. 
 
The preferred result of sub-threshold heating treatment is a large disc-shaped area of 
elevated HSPA expression. According to the hypothesis presented in Figure 29, disc-shaped 
HSP expression pattern could be achieved by lowering heating laser power as shown in 
Figure 29 B. However, due to the shape of the temperature profile, resulting area of 
elevated HSP expression is smaller than the heating laser spot [188]. The size of the heating 
laser spot is restricted by the size of the pupil. Therefore, in order to increase the area of 
HSPA expression without increasing the laser spot size, the retinal temperature profile 
should be top hat-shaped. This can be achieved by using a heating laser with an intensity 
that increases with distance from the beam center [188].  
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We did not observe a statistically significant difference in the lesion size between treatment 
factors 3 and 2.5. This may imply that the theory presented in Figure 29 is incorrect. 
However, it is also possible that the statistically significant difference was not observed due 
to the small temperature difference between the treatments, difficulties in determination 
of the lesion size or small sample size.  
 
 
 
 
Figure 29. Hypothetical presentation on how bell curve-shaped lateral retinal temperature 
profile yields (A) doughnut-shaped and (B) disc-shaped HSPA expression patterns.  
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8.3 Non-Linear Relationship Between Retinal Temperature Estimate and Power  
 
The ERG based temperature estimation method has been calibrated in vivo up to 42.5C 
and ex vivo up to 44C by Pitkänen et al. [15, 165]. They found linear behavior between b-
wave TTM and temperature up to these temperatures [15, 165]. The reliability of 
temperature estimation method in temperatures above 42.5C in in vivo is hence 
uncertain. However, based on the literature review (see Chapter 5.6.2.2) and preliminary 
testing of the method (unpublished data) it was estimated that higher temperatures than 
42.5C is needed for significant HSPA induction in response to 10 minutes heating. In order 
to allow usage of higher treatment temperatures, the method with a pre-heating step was 
used in this Master’s thesis.  
 
We observed that with high treatment heating powers the relationship between retinal 
temperature estimate and the heating laser power was non-linear (see Fig. 23). However, 
studies conducted by Baade et al. [187], Ibarra et al. [13], Hermann et al. [12] and Cain et 
al. [189] in rabbit as well as by Priebe et al. [190] in rhesus macaque indicate that retinal 
temperature during laser heating treatment increases linearly with increasing heating laser 
power. Therefore, it seems that the temperature estimation method used in this Master’s 
thesis is not capable to correctly determine the retinal temperature with the used 
treatment powers. Possible reasons for observed non-linearity include reaching of limit in 
the acceleration of b-wave TTM, the variation of temperature within the recorded retinal 
area, photoreceptor damaging, heating on top of the optic disk and cataract formation 
during experiment or combination of these effects.  
 
The used temperature estimation method is based on the acceleration of photoresponse 
kinetics in elevated temperatures that results in an observed linear decrease of b-wave 
TTM. The b-wave TTM, however, cannot decrease indefinitely. Dependence of the rate of 
biochemical processes on temperature is described by thermal performance curves (TPCs). 
Figure 30 illustrates the general shape of the TPC. Rate of the biological reactions typically 
increases as temperature increases until they reach a maximum point (Topt) after which the 
rates rapidly decrease. Even though TPCs tend to take the same general shape, the height, 
position in the x-axis, width and shape of rising and descending slopes can vary depending 
on the process in question. The shape of TPC is a result of the kinetics of biochemical 
reactions. The rising phase is typically exponential and is caused by an increase in the 
number and energy of thermal collisions between molecules. The descending phase of the 
curve, however, is attributed to enzyme deactivation caused by protein denaturation. [191] 
Additionally, the shape of TPC is affected by the temperature dependence of the 
probability of an enzyme being in its active state. Normally, this probability is lower in low 
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and high temperatures and arrives at the maximum at an intermediate temperature. TPCs 
are not only limited to biochemical reactions but also explain most biological rate processes 
at the whole organism level such as the growth and development of ectotherms. [192]   
 
The shape of TPC may explain the observed non-linear dependence of temperature on 
heating laser power. It is likely that b-wave TTM follows its own TPC. Therefore, when the 
temperature reaches Topt of b-wave TTM, the TTM does not increase anymore even though 
the temperature increases. We observed non-linearity already at the lowest treatment 
temperature and found no statistically significant difference in retinal temperature 
estimates. Therefore, in order to explain observed temperature estimate values, b-wave 
TTM TPC should have a plateau that covers all the tested temperatures.  
 
 
Figure 30. Hypothetical thermal performance curve (TPC) describing the relationship 
between the performance of a biological process and temperature. Topt is the temperature 
value at which performance is maximized. [191, modified] 
 
Another possible reason for the observed non-linearity is the variance in temperature 
within the heated retinal area. As discussed in Chapter 8.2, the middle area of the heating 
spot has a higher temperature than the distal areas. The temperature estimation is based 
on the recorded ERG signal that is a summation of photoreceptor and bipolar cell responses 
over the ERG stimulus spot. Pitkänen et al. [165] observed that in addition to the b-wave 
TTM, the b-wave amplitude decreases linearly with increasing temperature. They observed 
that the change of b-wave amplitude compared to the body temperature is 3.6% per 1C 
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for mouse ex vivo. [165] Therefore, the ERG signal arising from the hotter middle of the 
beam has smaller amplitude and TTM and thus participates less in the TTM determined 
from the recorded ERG signal compared to the cooler distal areas of the heating spot. This 
may result in temperature estimate values resembling the temperature of the distal areas 
of the heating spot. However, we tried to reduce this effect by using a smaller stimulus 
laser spot compared to the heating laser spot.   
 
Similarly, if the temperature at the center of the heating laser spot increases sufficiently to 
prevent the normal functioning of photoreceptor cells, these cells do not contribute any 
more to the recorded ERG signal and the retinal temperature estimate originates from 
surrounding cells with lower temperature. RPE cell damage was observed after heating in 
the middle of the heated area and therefore, it is possible that also the photoreceptor cells 
were damaged at the center of the heating spot. Furthermore, when heating close to the 
optic disk, no ERG signal is received from the areas that lack photoreceptor cells. This may 
have affected the retinal temperature estimate values in experiments where heating spot 
located close to the optic disk. 
 
An additional factor that may have contributed to the non-linearity of temperature is 
cataract formation during the experiment. It is possible that cataract formation during the 
course of the experiment prevented light passage to the retina and thus halted the retinal 
temperature increase. Cataract unlikely explains entirely the observed non-linearity since, 
in order to greatly affect retinal temperature during treatment heating, the cataract 
development should have occurred in a narrow time interval between the determination 
of power needed to reach 41C and the beginning of heating treatment which was not seen 
during the experiments. However, cataract formation may explain the small, gradual 
decrease of estimated retinal temperature during heating treatment observed in some of 
the experiments (see Figure 19 B).  
 
8.4 HSPA intensity 
 
We observed a statistically significant increase in the HSPA intensity of the whole flat-
mount of the treated eye compared to the control eye in tissues treated with treatment 
factor 3. In addition, we observed a strong correlation between flat-mount HSPA intensity 
and heating laser power as well as between flat-mount HSPA intensity and treatment 
factor. These results, however, need to be carefully interpreted due to several aspects 
affecting the staining intensity. These aspects include variation in dissection successfulness, 
staining process, light exposure, RPE melanin pigment content and small sample size. 
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Immunofluorescence images can be affected by tissue damage that has occurred during 
dissection or staining. Additionally, in some parts of the fluorescence images, a leftover of 
the neural retina was observed on top of the RPE. Lavinsky et al. [123] and Wang et al. [136] 
observed that at high temperatures, photoreceptor outer segments fuse to the RPE. This 
may result in a higher likelihood of leftover neural retina being in the heated area compared 
to the non-heated surrounding areas. We often observed remnants of the neural retina on 
top of the RPE cell layer in the middle of the heated area (see Figure 25 D). Therefore, the 
tendency of the neural retina to fuse with RPE in the heated area may have affected our 
results. 
 
Staining protocol is highly delicate and any alterations in the staining process may have 
induced variation in staining results. In addition, the fluorophores are sensitive to light. 
Light exposure reduces their fluorescence property due to irreversible light-induced 
damage. Therefore, the differences in the amount of light exposure either during staining, 
storing or imaging of tissue samples may induce intensity differences between tissues. In 
this Master’s thesis, the effect of these aspects was minimized by the following means. 
Firstly, the staining of all tissues was conducted by the same person. Secondly, heated and 
control tissues were stained and stored together. Thirdly, heated and control tissues were 
imaged together using the same microscope and imaging settings. Additionally, the 
alterations in the staining process or light exposure occur sporadically and do not cause 
systematic bias. Therefore, they cannot fully explain the obtained results. 
 
Additional difficulties in the analysis of HSPA staining intensity may arise from the high 
melanin content of RPE cells. RPE contains high amounts of melanin pigment which 
attenuates light that is passing through the RPE layer. Therefore, when imaging from the 
apical side of RPE, it is not possible to see stained HSPA proteins located in the basolateral 
side of the RPE cells. The depth to which HSPA can be detected depends on the pigment 
content of the cells. In addition, the damaging of cells during dissection or staining may 
reveal areas of the cell that are otherwise not visible by immunofluorescence microscopy. 
[193]  
 
Despite these factors that affect the staining intensity, we have clearly demonstrated that 
the laser heating treatment induces elevated HSPA expression in RPE cells. Similar results 
have been previously obtained by Kern et al. [135], by Lavinsky et al. [123] and by Wang et 
al. [136]. This promising result provides a solid base for further research on HSPA’s role in 
the laser heating treatment of AMD. 
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8.5 Future Perspectives  
 
The experiments of this Master’s thesis gave valuable insight on retinal heating treatment 
using the ERG based temperature estimation method. Even though HSPA-inducing non-
damaging treatment protocol was not achieved in this thesis, the obtained information can 
be used in the future to further develop the heating treatment protocol.  
 
In the future experiments, shorter heating duration or lower treatment factor should be 
used in order to prevent retinal damage. Shorter treatment duration would also reduce 
cataract formation. Additionally, shorter treatment duration reduces mouse anesthesia 
duration and is more applicable to the clinical setting. Besides the reduction of treatment 
factor or duration of the treatment, improvements related to the heating treatment 
protocol and the assessment of treatment outcome could be made.  
 
8.5.1 Heating Treatment 
 
The intensity profile of heating laser used in these experiments was not entirely 
homogenous (see Figure 18) and may have caused higher temperature areas within the 
heated area referred here as hotspots. At hotspot, the temperature increase can be 
significantly higher compared to the rest of the heated retina and result in choroidal vessel 
damage. The damaging of vessels may lead to even higher temperatures by preventing the 
cooling of tissue by blood flow. Therefore, hotspots can hypothetically cause severe burns 
to the retina during otherwise subthreshold heating. In order to reduce unwanted cellular 
damage during heating, a light source that produces more homogenous heating spot 
should be used in future experiments. 
 
In the majority of experiments, the heated area located near the optic disk. Optic disk, 
however, has different structure compared to the rest of the retina. It lacks photoreceptors 
and RPE and contains large retinal vessels [19]. Therefore, no temperature estimate values 
can be obtained from the optic disk. Additionally, structural differences may result in 
deviant temperature profile and response to temperature elevation compared to the rest 
of the retina. In future experiments, the heating of the optic disk should be avoided. The 
current heating laser spot is approximately the same size as the mouse pupil. The laser spot 
covers the majority of the visible part of the fundus and there is only limited possibility to 
select the heated area within the visible fundus. In order to allow a more precise selection 
of the heating area within the visible area, a smaller spot should be used. Alternatively, the 
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angle between the eye and the fundus lens can be adjusted in a way that the optic disk is 
outside of the visible area of fundus.  
 
In this Master’s thesis, the heated location of the retina was unknown. It was assumed that 
the observed doughnut-shaped HSPA expression patter located in the center of the heating 
laser spot. In order to gain more definitive information about the location of the heating, 
methods to mark the heating laser spot location should be investigated. One possibility is 
to induce small, intense marker burns outside the heating laser spot to mark the location. 
Additionally, the retinal imaging capabilities of the heating device could be improved in 
order to better visualize the heated area.  
 
8.5.2 Assessment of Treatment Outcome by Immunohistochemistry  
 
Immunohistochemical staining is best suited for the localization of target proteins and gives 
only limited information about the amount of target protein. In this Master’s thesis, the 
HSPA staining intensity was assumed to have a direct relationship with the amount of 
retinal HSPA. However, due to reasons discussed in Chapter 8.4, this assumption might be 
somewhat misleading. More reliable quantitative information about HSPA can be achieved 
by Western blot method. However, disadvantages of the Western plot include the need for 
many RPE samples for single analysis and lack of ability to determine the localization of 
detected target proteins in the tissue.  
 
Based on cell structure changes observed in phalloidin staining, it was hypothesized that 
the observed dark area inside circular high-intensity HSPA staining is caused by the death 
of cells that were exposed to lethal temperature increases. However, this hypothesis needs 
to be confirmed by staining of apoptosis and necrosis markers. Additionally, the timing of 
staining may need to be adjusted. In this Master’s thesis, the staining was conducted 24 
hours after the heating treatment. This time-point was selected based on literature to yield 
high HSPA amounts in RPE (see literature review in Chapter 5.6.2.2). However, it has been 
observed by Kern et al. [135] that apoptotic cell death may occur between 24 and 48 hours 
after laser heating. They also hypothesize that some of the cells strongly expressing HSPA 
at 24 hours are under apoptosis [135]. If their hypothesis is correct, it would be beneficial 
to conduct the staining later in order to gain more accurate information about the extent 
of cell death.  
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In addition to measuring HSPA expression after treatment, treatment’s effect on other 
biomolecules should be investigated. Even though the expression of HSPA after 
hyperthermia is a well-known phenomenon, it may not contribute to the prevention of 
AMD development or other more essential mechanisms may exist. Other potential 
treatment mechanisms that were discussed in Chapter 5.6.2.1 include RPE regeneration, 
reduction of angiogenesis, enhancement of mechanism protecting RPE cells against 
oxidative stress and thinning of Bruch’s membrane. All these mechanisms could be studied. 
Yet, additional potential treatment mechanisms may exist. All in all, more information 
about the pathogenesis of AMD is needed to better understand which cellular mechanisms 
could be utilized to prevent the progression of this disease.  
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9. Conclusions 
 
The purpose of this Master’s thesis was to study how laser heating treatment affects the 
retinal function in mice. In addition, this Master’s thesis reviewed the function and 
regulation of HSPA as well as the pathogenesis of AMD and its current treatment 
modalities. The study was conducted as a part of ongoing research in the Department of 
Neuroscience and Biomedical Engineering (NBE) of Aalto University aiming to develop a 
novel heating treatment for AMD. 
 
In this Master’s thesis, we observed substantial variation in the power needed to reach the 
same temperature increase in different mice. This finding supports the usage of 
temperature estimation method during non-damaging retinal heating treatment. 
Additionally, we found that the dependence of estimated retinal temperature on heating 
laser power is non-linear. However, the reason for non-linearity was not revealed and 
requires further research. 
 
We observed a statistically significant increase in HSPA intensity in tissues treated with the 
highest treatment factor compared to control tissue. Additionally, we found that HSPA 
intensity correlates with heating laser power and treatment factor. We observed similar 
HSPA expression pattern in all the used treatment factors. This pattern consisted of an area 
with low HSPA intensity surrounded with circular high HSPA intensity area. The central area 
showed signs of cellular damage in phalloidin staining and was associated with cell death. 
Based on our results, in future experiments, one should use a lower treatment factor or 
shorter treatment duration in order to reduce the amount of heat-induced retinal damage.  
 
In general, more information about the pathogenesis of AMD is required to better 
understand which cellular mechanisms could be utilized in the treatment of the disease. In 
addition, the capability of heating treatment to regulate these mechanisms needs to be 
investigated. The ERG based retinal temperature estimation method offers a novel way to 
personalize heating laser power during retinal heating treatment and can be used in the 
future to uncover how retinal tissue responds to heat. Our results can be used as the 
foundation for further research on the subject. 
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A.1 
 
Appendix 
 
This appendix contains larger versions of the images of stained and flat-mounted RPEs after 
heating with treatment factors 2, 2.5 and 3 presented in the body text. In these figures, the 
arrow indicates the location of the optic disk. The right eye of the mouse was always treated 
and the left eye acted as a control. 
 
 
Figure A1. Stained and flat-mounted RPE after heating with treatment factor 2. HSPA 
staining of the control eye. This figure is the same as Figure 24 A presented in the body text. 
A.2 
 
 
Figure A2. Stained and flat-mounted RPE after heating with treatment factor 2. HSPA 
staining of the treated eye. This figure is the same as Figure 24 B presented in the body text.  
 
 
Figure A3. Stained and flat-mounted RPE after heating with treatment factor 2. Close-up 
image of the heated area. Image borders are indicated with a dashed rectangle in Figure A2. 
This figure is the same as Figure 24 C presented in the body text. 
A.3 
 
 
Figure A4. Stained and flat-mounted RPE after heating with treatment factor 2. Phalloidin 
staining of the center of heated area. The location of the white dot is the same as in Figure 
A3. This figure is the same as Figure 24 D presented in the body text.  
 
 
Figure A5. Stained and flat-mounted RPE after heating with treatment factor 2.5. HSPA 
staining of the control eye. This figure is the same as Figure 25 A presented in the body text. 
A.4 
 
 
Figure A6. Stained and flat-mounted RPE after heating with treatment factor 2.5. HSPA 
staining of the treated eye. This figure is the same as Figure 25 B presented in the body text.  
 
 
Figure A7. Stained and flat-mounted RPE after heating with treatment factor 2.5. Close-up 
image of the heated area. Image borders are indicated with a dashed rectangle in Figure A6. 
This figure is the same as Figure 25 C presented in the body text.  
A.5 
 
 
Figure A8. Stained and flat-mounted RPE after heating with treatment factor 2.5. Phalloidin 
staining of the center of heated area. The brighter area at the center of the figure is probably 
neural retina that was not properly removed during dissection. The location of the white dot 
is the same as in Figure A7. This figure is the same as Figure 25 D presented in the body text.  
 
 
Figure A9. Stained and flat-mounted RPE after heating with treatment factor 3. HSPA 
staining of the control eye. This figure is the same as Figure 26 A presented in the body text. 
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Figure A10. Stained and flat-mounted RPE after heating with treatment factor 3. HSPA 
staining of the treated eye. This figure is the same as Figure 26 B presented in the body text.  
 
 
Figure A11. Stained and flat-mounted RPE after heating with treatment factor 3. Close-up 
image of the heated area. Image borders are indicated with a dashed rectangle in Figure 
A10. This figure is the same as Figure 26 C presented in the body text. 
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Figure A12. Stained and flat-mounted RPE after heating with treatment factor 3. Phalloidin 
staining of the center of heated area. The location of the white dot is the same as in Figure 
A11. This figure is the same as Figure 26 D presented in the body text.  
 
